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ABSTRACT 
 An analog to the active form of the signal transduction protein CheY is produced, 
purified, and crystallized herein.  The analog, which was named phosphono-CheY, is 
synthesized to mimic the in vivo active form of CheY known as P-CheY; P-CheY only 
has a half-life of ~30 seconds, making it extremely difficult to study.  P- CheY is 
produced by the phosphorylation of an aspartate residue on CheY by the histidine kinase 
CheA.  Subsequently, P-CheY binds to the flagellar motor protein FliM and switches the 
flagella’s rotational direction.  P-CheY becomes dephosphorylated by the phosphatase 
CheZ (in E. coli) or the phosphatases CheC/D, CheX, FliY/N (in T. maritima) to change 
the flagella rotation back to its previous state.  The binding and release of P-CheY from 
FliM causes the bacteria to exhibit periods of smooth swimming and tumbling motions 
which drive the bacterium out of harsh environments and into nutrient rich ones; these 
events define bacterial chemotaxis.  phosphono-CheY is synthesized in order to replace 
the labile P-O bond in P-CheY with a stable P-C bond; this will allow for 
crystallographic data and binding assays to be performed without degradation of the 
protein.  phosphono-CheY is produced by reacting CheY with phosphonomethyltriflate 
(PMT) in the presence of 3.0 equivalents of triethylamine and 125 mM Ca2+.  Typically, 
this reaction will result in 45-70% conversion of CheY to phosphono-CheY, meaning a 
purification step must be performed subsequently.  Purification was successful using 
cation exchange HPLC with a 50 mM sodium acetate buffer at pH = 5.3.  The gradient 
was run from 0 to 11.7% mobile phase B over 47 minutes and pure phosphono-CheY 
eluted at 31 minutes and CheY at 23 minutes.  Crystallization trials modeled after those 
for unmodified CheY from T. maritima were applied and diffraction quality crystals were 
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grown in wells that contained the following: PEG 3400 (26%)/100 mM HEPES (pH = 
7.0)/.2 M (NH4)SO4/15 mM MgCl2, PEG 3400 (28%)/100 mM acetate (pH = 4.5)/.2 M 
(NH4)SO4/15 mM MgCl2, PEG 4000 (26%)/100 mM HEPES (pH = 7.0)/.2 M 
(NH4)SO4/15 mM MgCl2, and PEG 4000 (28%)/100 mM acetate (pH = 4.5)/.2 M 
(NH4)SO4/15 mM MgCl2. 
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INTRODUCTION 
Bacterial Signal Transduction and Two-Component Systems 
The ability of bacteria to sense small environmental changes with high sensitivity 
is important for bacterial survival.  Environmental changes provoke response from 
bacteria by the relay of information about the environment from extracellular receptors 
on the surface of the bacteria to their ultimate target downstream to an intracellular target 
protein.  This relay of information is known as signal transduction, where an external 
signal is processed and passed between various intracellular signaling proteins while 
being amplified for increased sensitivity (1).  Bacteria can regulate a number of important 
processes by sensing external stimuli arising from various environmental changes; such 
processes as growth and development, metabolic regulation, and chemotaxis are 
controlled this way (2).    
Signaling proteins in a signal transduction pathway are regulated both covalently 
and non-covalently; however, both serve the same purpose, to modify the protein in such 
a way an alteration in its structure occurs.  This conformational change is crucial in the 
activation/deactivation of certain proteins which will allow the signal to either continue 
along the pathway or stop at a particular point.     
The most prevalent signal transduction scheme in bacteria is described as a two-
component system (1).  These systems all share a common mechanism in which a high-
energy phosphoryl group is transferred from a histidine autokinase protein to a conserved 
aspartate residue of a response regulator protein (3,4).  Response regulator proteins 
interact directly with their effector protein, and they are turned on and off by 
phosphorylation/dephosophorylation.  Again, the structural change in the protein upon 
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phosphorylation will allow the protein to interact with its effector in a way which its 
unphosphorylated structure cannot (3,4).   
A typical example of this mechanism lies within the signal transduction pathway 
that constitutes osmoregulation in bacteria.  This system contains a histidine kinase 
protein EnvZ which transfers a phosphoryl group to the response regulator protein 
OmpR, therefore activating it.  Upon activation of OmpR, a conformational change in the 
protein enables it to bind to DNA and regulate the transcription of genes that encode for 
the proteins OmpC and OmpF (5,6).  These proteins are outer membrane porin proteins 
which control water movement into and out of the cell (5,6).  The most widely studied 
response regulator however, lies within the two-component system which regulates 
chemotaxis in bacteria, this response regulator is CheY. 
 
Bacterial Chemotaxis 
 CheY is the response regulator protein directly responsible for chemotaxis in 
bacteria; when it becomes activated, it interacts directly with its effector protein FliM.  
Chemotaxis is the phenomenon which explains the movement bacteria exhibit in 
response to an external chemical gradient; it is characterized by periods of smooth 
swimming and tumbling motions the bacteria show as they rotate their flagella either in a 
clockwise (CW) or counterclockwise (CCW) direction.   
The flagella motor (Figure 1) is a complex structure made up of >20 different 
proteins and five main rings named the L,P,M,S, and C rings. The L and P rings are made 
up of the hydrophobic membrane proteins FlgH and FlgI which serve as bushings.  The S 
and M rings (commonly referred to together as the MS-ring) are formed from ~26 copies 
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of the protein FliF and is located in the cytoplasmic membrane.  The 5th ring, which is 
associated to the MS-ring by the multidomain protein FliG, is called the C-ring, and is 
composed of FliM and FliN.  Together, FliM, FliN, and FliG form a switch complex 
which is essential for torque generation, binding of CheY-P, and motor rotation (7,8). 
During chemotaxis, a bacterium will swim toward an area which is rich in a 
chemoattractant (such as glucose), and tumble away from one which is rich in a 
chemorepellant (such as phenol).  In bacteria such as Escherichia coli, CheY is 
phosphorylated at Asp57 by the histidine kinase CheA in the absence of chemoattractant 
and dephosphorylated by the phosphatase CheZ when chemoattractant is present.  The 
transition of the phosphoryl group from CheA to CheY involves a His-Asp phosphate 
transfer mediated by chemoacceptors or methyl-accepting chemotaxis proteins (MCPs) 
on the surface of the bacteria; the MCPs are methylated by CheR and demethylated by 
CheB.  E.coli cells contain five chemoreceptors: Tsr, Tar, Tap, Trg, and Aer which sense 
attractant and repellant stimuli (9).  Attractant stimuli interact with the chemoreceptors to 
inhibit CheA activity by demethylation of the MCPs by CheB, while a repellant stimulus 
enhances CheA activity by methylation of MCPs by CheR to allow for phosphate transfer 
to CheY (7,8).  Phosphorylated CheY (CheY-P) will subsequently bind to FliM on the 
flagella motor to promote clockwise (CW) rotation of the flagella. The CW rotation will 
switch the bacteria from a smooth swimming state to a state in which the bacterium 
exhibits a tumbling motion.  As the bacteria enters a more attractant rich environment, 
binding of attractant to surface receptors on the bacteria causes blockage in the signaling 
pathway leading to CheY phosphorylation.  As this happens, P-CheY is hydrolyzed with 
help of the phosphatase CheZ and the adapter protein CheW, causing P-CheY 
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concentration to drop and the bacteria to swim smoothly.  Overall, the bacteria exhibit a 
biased random walk towards conditions where there is an attractant-rich environment 
(10,11). 
 In other bacteria, such as Bacillus subtilis and Thermotoga maritima, bacterial 
chemotaxis works somewhat differently.  For one, chemoattractants cause the 
phosphorylation of CheY by CheA; two, CheY is phosphorylated at Asp54 homologous 
to Asp57 in E. coli; and three, the binding of CheY-P to the flagella motor induces a 
CCW rotation rather than CW rotation (12).  Another difference, and perhaps the most 
important, is the presence of 3 proteins not present in the E.coli chemotaxis system. 
These 3 proteins are the phosphatases CheC/D, CheX, and FliY/N (12,13).  CheC in this 
case is of particular importance because of its high sequence identity to the bacterial 
motor protein FliM which P-CheY binds to (13).  Because CheC is suspected to be more 
soluble than full-length FliM, a CheY/CheC complex would be easier to crystallize and at 
the same time will give insight on the CheY/FliM complex. 
 Because CheY-P is labile (its half-life on the order of only a few seconds) (14), 
synthesis of a stable analog is desired.  In order for a stable analog of CheY to be 
synthesized, the methods used to create phosphono-CheY from a mutant CheY in E. coli 
(15) will be applied to a mutant form of CheY from T. maritima (D54C/C81S) in order 
for crystallization and binding studies.  In this instance the non-active Asp54 residue is 
mutated to a cysteine to introduce a nucleophilic site for modification.  This mutation 
allows a formation of a stable S-C bond, which replaces the labile C-O bond in wild type 
P-CheY.  Modification is done by nucleophilic attack of the sulfhydryl group of sulfur on 
the alkylating agent phosphonomethyltriflate (PMT) in the presence of triethylamine and 
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metal ion.  Figure 2 shows the schematic of both wild type phosphorylation (in vivo) and 
in vitro phosphorylation of the mutated form of CheY.  It should be noted that the 
cysteine residue at position 81 is mutated to a serine in order to prevent modification at 
both Cys54 and Cys81.  Triethylamine is used to counteract PMT protons and metal ion 
is used for several reasons; it perturbs the pKa of the cysteine downwards and it is 
believed to bring PMT closer in proximity to the active site.  By bringing PMT closer to 
the active site, easier nucleophilic attack of sulfur can occur.  In some enzymes, 
phosphoryl groups have high affinity for metal ion and will chelate them; in our case, 
metal ion will bring PMT to the active site of the protein because of its phosphoryl group.   
    Phosphono-CheY is a stable analog of CheY-P which was successfully used for 
crystallization studies as well as binding studies of phosphono-CheY to peptides 
mimicking CheZ in E. coli (16,17).  Binding studies were carried out using fluorescence 
and isothermal titration calorimetry (ITC) to give information on dissociation constants 
between phosphono-CheY and CheZ (18).   
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Figure 1.  Structure of the Flagella motor. 
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Figure 2.  Schematic of CheY phosphorylation both wild type and in vitro.  The top mechanism represents 
in vivo phosphorylation of CheY.  Here CheA transfers the phosphoryl group obtained by ATP to the 
Asp54 of CheY; this forms a labile C-O bond which has a half life of ~ 30s.  The bottom mechanism 
represents the chemistry in the phosphonomethylation reaction performed with PMT.  Here the mutated 
active site Cys54 attacks PMT at the carbon next to the triflate leaving group forming a stable S-C bond.  
The result of this reaction is a structure which is analogous to wild type P-CheY. 
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MATERIALS AND METHODS 
Production and Purification of D54C/C81S CheY from Thermotoga Maritima 
T. maritima D54C/C81S CheY cloned into a pet28a(+) vector encoded with an N-
terminal hexahistidine-tag (his-tag) was  provided by the laboratory of Brian Crane at 
Cornell University. The plasmid was transformed into E. coli cell line B834 (DE3).  The 
his-tag on CheY in this case is a sequence of 6 histidine residues at the N-terminus of the 
protein; it is used for purification purposes which will be discussed below. 
 First, 50 mL of Terrific Broth (TB) (Appendix 1) solution is inoculated overnight 
with D54C/C81S CheY cells from the BE834 (DE3) cell line. 15 µg/mL kanamycin 
(syringe filtered as 30 mg/mL stock) is added to the solution and it was incubated at 37 
°C while shaking at ≥ 200 RPM.  The next morning two 1 L TB solutions are inoculated 
with 25 mL from the overnight cultures; again 15 µg/mL of kanamycin is added.  The 
growth is incubated at 37 °C while shaking at ≥ 200 RPM.   Throughout the growth, the 
optical density (OD) of the solution is monitored by taking the absorbance of the solution 
at 600 nm.  Using DI water as reference, absorbance at 600 nm is monitored until OD600 
reaches 1 – 1.5.  At that point, the solutions are induced with 0.2 mM IPTG (syringe 
filtered as 1 M stock) and continue shaking at 37 °C for 4 – 7 hrs.  The cells are then 
harvested at 11,468 RCF x g for 20 minutes at 4 oC, followed by pouring off the 
supernatant.  At this point the cell pellets can either be frozen on dry ice and kept at -80 
°C or they are prepared for sonnication.  
The cells are gently suspended in ≤ 5 mL of lysis buffer (Appendix 1) per 1 gram 
of wet cell weight and 1mM PMSF,  ≤ 10mM 2-mercaptoethanol (or ≤ 1 mm 
dithiothreitol), and 1 µM leupeptin and pepstatin are added to this solution.  Sonnication 
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of the cells is then done in a stainless steel beaker while chilling the cells to 2 – 3 °C in an 
ice water/salt bath between bursts.  The cells are sonnicated until the solution is 
homogenous and an obvious change in color is seen (light to dark); the cells are checked 
under a light microscope at 1000x magnification to ensure sonnication worked properly. 
Typically live cells are rod shaped and “buzz” around in solution while dead cells are 
more round and lack any type of movement. When the cells appear to be broken, the 
lysate is poured into centrifuge tubes and spun at 38,828 RCF x g for 65 min at 4 oC.  The 
supernatant is now the soluble fraction and the pellet is the insoluble fraction.  Both the 
soluble fraction and pellet are checked for the presence of CheY by SDS-PAGE before 
proceeding; molecular weight determination is determined as compared to broad range 
standards from Novagen.  
After centrifugation, a 5 mL (10 mL of a 50% slurry) Ni2+-NTA (nitriloacetic 
acid) column by Novagen is used to purify His-tagged CheY.  The column is equilibrated 
with 10 column volumes of lysis buffer first before syringe filtering the sonnication 
supernatant onto the Nickel column.  After loading the lysate, the column is washed with 
2 – 5 column volumes of wash buffer; the elution from the column is collected and 
checked via SDS-PAGE (this usually contains some CheY and can be rerun over the 
Nickel column).  CheY is then eluted with ~ 10 mL of elution buffer (imidazole competes 
with the His-tag for nickel chelation sites).  The elution volume is kept as small as 
possible (3 % of the volume of the size exclusion column used in the final step).  It is 
easy to follow the path of the protein on the Nickel column, as the color changes with 
each step.  As the protein binds, the column changes from green to white.  Washing the 
column produces a purple color at the top.  Elution turns the white column back to green-
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blue and collection of the elution is stopped shortly after all the white color is gone. The 
elute from the column is then checked via SDS-PAGE to ensure the presence of CheY 
before proceeding.  The nickel column is regenerated after every five uses, or when the 
resin turns a brownish/yellow color; the regeneration protocol can be seen in Appendix B. 
Protein concentration is determined by Bradford assay (using a standard curve 
constructed from known stock concentrations of egg albumin) first before thrombin 
digestion.  Thrombin digestion is employed to cleave the his-tag off the protein. Using 
high purity grade thrombin from MP Biomedicals, 1:2000 w:w (thrombin:protein) or 0.5 
activity units (NIH units) per mg of protein is added to the protein along with 2.5 mM 
CaCl2 and 5 mM MgCl2.  The reaction is left to proceed overnight (16-22 hours) while 
shaking at room temperature.  After ~16 hours the digestion is checked via SDS-PAGE to 
check for completion; this is compared to a small sample of CheY taken before digestion 
to have a band to compare the digest to.   
 After digestion is completed, a Sephadex G-50 size exclusion column is used to 
separate thrombin, CheY and his-tag.  The molecular weight cutoff of G-50 is slightly 
below the molecular weight of thrombin so it will elute in the void volume, and sufficient 
separation between pure CheY and the his-tag (2 KDa) is achieved.  The column used is 
95 cm high and 2.5 cm in diameter (466 mL); it is poured under flowing conditions as 
uniformly as possible at 4o C.  For best separation, the volume of the sample is kept at 
less than 3% of the column volume, or 14 mL in this case (19).  Prior to loading the 
column, 1 L of phosphate buffer (pH 6.8 - 7.2) with 25 mM β-mercaptoethanol and 
0.02% azide is run through the column to equilibrate it.  Once equilibration is complete 
the protein is loaded to the top of the column bed while being careful not to disturb the 
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gel.  After the sample is loaded, a few mL of elution buffer is used to rinse the sides of 
the column.  A fraction collector is set up to collect 7 min fractions off the column while 
the flow rate is slightly less than 1 mL/min to give fractions of ~6 mL.  The fractions are 
collected overnight and analyzed by A280 nm the following morning.  As absorbance is 
monitored three peaks in absorbance are observed, eluting at approximately 150 mL, 250 
mL, and 500 mL of buffer.  Analysis of the fractions by SDS-PAGE and UV-VIS 
spectroscopy confirms the 2nd peak as CheY.  The fractions are then pooled based on the 
above analysis methods and is concentrated using an Amicon concentrator with a YM3 or 
PLBC 3,000 molecular weight cutoff membrane (Millipore).  The protein is concentrated 
to ~7.5 mg/mL and is aliquoted out in 1 mL fractions and quick frozen to store at -80 oC.  
Preparations of CheY were denoted as A, B, C, etc. in order of when they were prepared.  
For example, protein prepared from two 1 L growths preformed side by side at the 
beginning of a new year is called prep. “year”A. 
 
Phosphonomethylation of D54C/C81S CheY from T. maritima 
 D54C/C81S CheY stored in 50 mM phosphate, pH 6.8, is taken out a night before 
a reaction is to be performed. The aliquot is thawed and 10 mM 2-mercaptoethanol, 1 
mM DTT or 10 mM bis-2-mercaptoethylsulfone (BMS) is added to allow for full 
reduction overnight; all of these reducing agents worked equally well in this case.  The 
following day the protein is concentrated in a Centriprep (Millipore) or Nanosep (Pall 
Life Sciences) concentrator, both with molecular cutoff weights of 3,000.  The protein is 
concentrated to 250-300 µL for buffer exchange via 2 Penefsky spin columns (20) 
performed back-to-back. For volumes 150 µL and less 1 Penefsky column is adequate, 
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though one can always ensure proper buffer exchange by testing with pH paper. The 
protein is exchanged into 250 mM TAPS buffer, pH 8.25 and diluted up to 750 µL for a 
final protein concentration around 8.5 mg/mL as confirmed by Bradford assay or UV 
scan.  A molar absorptivity of 2560 cm-1M-1 is used for the A280 obtained via UV scan.  
This molar absorptivity value was calculated from experiments done with Matthew Haas, 
and data can be seen in his Masters thesis (21).  An assay using 5,5-dithiobis(2-
nitrobenzoic acid), or DTNB, is used to measure protein free thiol content (22), and the 
A410 of the protein is monitored over 40 minutes. It is desirable for the protein free thiol 
content to be 75% or greater.  The experiment is setup in a 1 mL plastic cuvette 
containing 950 µL of 0.100 M potassium phosphate buffer (pH = 7.2) and 50 µL 20 mM 
DTNB solution.  The UV spectrophotometer is equilibrated at 25oC and the blank (water) 
and DTNB solution are placed in the cell changer to allow for temperature equilibration.  
After ~10 minutes of temperature equilibration a time drive assay is performed to 
monitor the change in absorbance of the DTNB solution over time after protein is added.  
A proper amount of protein is added to allow for a change of absorbance approximately 
equal to 0.100 AU.   
Once the DTNB assay has ensured substantial reduction of the protein, the protein 
is split into 3-250 µL aliquots and 125 mM of BaCl2, CaCl2, or SrCl2 is added.  Trivalent 
metals such as Tb3+, Lu3+, and Nd3+ were also used and will be discussed later.  120 mM 
phosphonomethyltriflate (PMT) is weighed out on a 5-place balance as quickly as 
possible to avoid water hydrolysis. 3.0 equivalents of dried and distilled Et3N is added to 
remove the two protons from PMT and the one from the sulfhydryl group on the cysteine 
residue. Half the volume of Et3N needed of EtOH is added to PMT and mixed until PMT 
13 
is dissolved. As quickly as possible, the Et3N is added to the PMT/EtOH mixture and 
transferred into the protein/metal mixture. This solution is mixed and left to stand for 30-
45 minutes at room temperature; typically a precipitate will form upon addition of PMT 
mixture to protein.  pH is monitored with pH paper to ensure the pH does not drop too 
low upon the addition of PMT. After the alkylation is complete, the protein is centrifuged 
in a microcentrifuge to remove any precipitate and it is buffer exchanged into a buffer 
which is used in cation-exchange chromatography (described later) via a PD-10 desalting 
column (23). A DTNB assay is preformed to reevaluate the percentage of free thiol after 
the modification is done. A percentage decrease of at least 50% is desirable. A sample is 
also taken for HPLC analysis at this point (described below).  If the protein is not to be 
purified immediately, 10 mM 2-mercaptoethanol is added and the protein is quick frozen 
and stored at -80 oC.  
Many different conditions were used in phosphonomethylation reactions, though 
the conditions used above were the most consistent and reliable.  Other methods 
attempted will be discussed in the results section. 
 
Reversed Phase HPLC analysis of Phosphonomethylation Reactions 
 Reversed Phase HPLC (RP-HPLC) is the preferred method for analyzing the 
extent of modification to our protein. Both HP1050 and HP1100 HPLC systems are used; 
each contains a quaternary pump, degasser, and column heater, while the 1050 contains a 
variable wavelength detector and the 1100 a diode array detector.  Absorbance at 215 nm 
is read with both the HP1050 and HP1100, as this is the amide bond absorbance region.  
Additionally, the absorbance at 280 nm is read on the HP1100 with the diode array 
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detector for absorbance of aromatic amino acids.  Two different columns are used in 
analysis; one a 4.6 mm ID x 250 mm Vydac C18 Protein and Peptide column with a 300 
Å pore size, and the other a 2.1 mm ID x 250 mm column of the same packing. A 2 
micron pre-column and the appropriate guard column are also used on both instruments. 
The 2.1 mm ID column is preferred in most cases since it saves on both mobile phase and 
sample. A flow rate of 0.200 mL/min is used for the 2.1 mm ID column (giving pressures 
between 56 and 70 bar), while a 1.00 mL/min flow rate was used for the 4.6 mmID 
column (giving pressures between 115 and 121 bar). The mobile phases are acetonitrile 
(ACN) and water with triflouroacetic acid (TFA) used as an ion-pairing agent. Mobile 
phase A (MPA) is 95% H2O/ACN with 0.1% TFA, mobile phase B (MPB) is 80% 
ACN/H2O with 0.08% TFA, and mobile phase C (MPC, used for column storage) is 50% 
ACN/H2O with no TFA. For the 2.1 mm ID column, 15 µg of protein is loaded, while 45 
µg is loaded for the 4.6 mm ID column. The gradients used employ an increasing 
percentage of ACN; for the 2.1 mm ID column the gradient runs from 47% MPB to 54% 
MPB over 50 minutes (though variations were used), and from 45% MPB to 53% MPB 
over 50 minutes for the 4.6 mm ID column.  CheY elutes toward the end of the gradient 
at ~45 minutes and P-CheY elutes earlier (more polar) at ~27 minutes. If the HPLC 
analysis shows a clean reaction (meaning no more than 2 major peaks) and at least 40% 
modification, cation-exchange HPLC will be used to purify the sample (see below). 
 
Purification of Phosphono-CheY from T. maritima 
 Purification is carried out using cation-exchange HPLC (CEX-HPLC); again, HP 
1050 and 1100 HPLC systems are used.  A PolyCAT A 9.4 mm ID x 200 mm 1000 Å 
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weak cation-exchange column is used for preparative work, while a 4.6 mm ID x 200 mm 
1000 Å column of the same type is used for analytical work. A flow rate of 3.00 mL/min 
is used for the 9.4 mm ID column, while a 1.00 mL/min flow rate is used for the 4.6 mm 
ID column. 100 µg is sufficient for the 4.6 mm ID column, while up to 3 mg of a crude 
phosphono-CheY mixture is sufficient for the 9.4 mm ID column. The buffers used for 
CEX must be about 2 pH units lower than the theoretical pI value of CheY, which is 
calculated to be 8.68. MPA is one of low salt while MPB is one of high salt; a gradient of 
increasing salt is used to elute bound proteins.  Four different mobile phases were used in 
purification of phosphono-CheY, they are as follows: 10 mM potassium phosphate 
buffer, pH 6.20, 25 mM sodium acetate buffer, pH 5.00, 25 mM MES buffer, pH 5.8, and 
50 mM sodium acetate buffer, pH = 5.3.  All MPA buffers contained only buffer salt, 
while all MPB buffers contained buffer salt plus 500 mM NaCl. Prior to sample injection, 
the sample is always buffer exchanged into the appropriate MPA buffer which is to be 
used in the purification. Certain problems were present in each buffer, and these will be 
discussed in the Results section.  Appendix C further explains cation exchange HPLC 
techniques. 
 
Crystallization of Phosphono-CheY from T. maritima 
 Crystallization conditions of phosphono-CheY are modeled after known 
conditions for unmodified CheY from T. maritima; hanging drop diffusion is the 
preferred method of crystallization (24). Wells contain 500 µL of solution, (precipitant 
plus buffer and metal) while silanized glass cover slips contain 2 µL of protein plus 2 µL 
of well solution.  Protein is concentrated to ~8.5 mg/mL and buffer exchanged via a 
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Penefsky spin column into pH 7.8 buffer containing 10 mM triethanolamine, 25 mM 
NaCl, 1 mM EDTA, and 1 mM NaN3.  The wells contain 200 mM ammonium sulfate and 
various PEG molecular weights and concentrations for the precipitant. 15 mM MgCl2 is 
always present, and 100 mM buffer is used.  After all solutions are present in the well, the 
plate is stirred on a rotating plate for ~20 minutes to allow for homogenization of the well 
solution.  Before glass slips are suspended above the well solution, the plates are pre-
greased with petroleum jelly or some other sealing lubricant.  
All pipette tips used are autoclaved and all solutions are made up in Mill-Q water 
and filter sterilized with 0.25 µm filters with the exception of PEG solutions, which are 
filtered with 1.2 µm filters under vacuum. Buffers ware made up as 1 M stock solutions 
and PEGs were made up as a 50 % w/v solution. 
 
Synthesis of Phosphonomethyltrichlorosulfonate 
 A full reaction scheme can be seen in Figure 3 with each molecule numbered.  
This procedure involves sulfinylation of our starting alcohol, dibenzyl hydroxymethyl 
phosphonate (dibenzyl-HMP) (1), using trichloromethansulfinyl chloride (ClSOCCl3), 
followed by oxidation with a sodium periodate/ruthenium system as used by Sharpless et. 
al. (25,26).  
 Sulfinylation of the starting alcohol is carried out at room temperature under 
N2(g) atmosphere, A solution of  2.3 eq. of ClSOCCl3 in CH2Cl2 is combined with a 
stirred solution of starting alcohol (1) with 2.5 eq. 2,6-lutidine in CH2Cl2 by dropwise 
addition. The reaction is left to stir for 30 minutes (27), a small amount of precipitate 
formed and the solution turned slightly orange.  The reaction is diluted up with CH2Cl2 
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and washed twice with 4% CuSO4.  The original protocol calls for a 2N H2SO4 wash, 
however this was modified in order to prevent the use of strong acid (26).  The organic 
layer is dried with MgSO4, filtered, and solvent removed by rotary evaporation.  Sulfinate 
ester (2) is produced as confirmed by 1H NMR and will be discussed in the results 
section. 
Sulfonylation is carried out at room temperature by adding 2.0 eq. of NaIO4 and 
0.2% mol of RuCl3 to a stirred solution of sulfinate in a 5:1 acetone/H2O solvent system    
(A 3:2 ACN/water solvent system was also used successfully). The reaction is left to stir 
for two hours; typically the reaction will turn a dark green due to a ruthenium species 
(27).  The reaction is then diluted with CH2Cl2 and washed twice with water. The organic 
layer is dried, filtered, and solvent removed by rotary evaporation to yield a solid light 
brown product.  In some cases it may be necessary to employ a small silica column to 
remove the green ruthenium precipitate that forms during the reaction.  Sulfonate ester 
(3) is produced as confirmed by 1H NMR and will be discussed in the results section. 
The final step is hydrogenation of the benzyl groups connected to the alcohol.  
The sulfonate (3) is dissolved in dry ethanol and has Pd/C catalyst added to it; it is then 
put under hydrogen gas (~40 psi) for 1 hour.  Removal of the Pd/C is done by vacuum 
filtration through celite and volatiles are removed via rotary evaporation.  The final 
sulfonate ester (4) is produced and confirmed by 1H NMR analysis. 
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Figure 3.  Full reaction scheme for the production of phosphonomethyltrichloromethylsulfonate. 
 
 
 
 
 
19 
RESULTS 
Purification of D54C/C81S CheY from thermotoga maritima 
 SDS-PAGE is used to check each step of the nickel column to monitor CheY.  If 
the CheY band is strong in the SDS-PAGE of the load the lysate, it is re-run back over 
the nickel column.  Washing and eluting steps of the column are also monitored by SDS-
PAGE to identify any possible CheY left behind.  Figure 4 shows an SDS-PAGE gel of 
each step on the nickel column purification.  Here there are 4 different lanes used in the 
gel; the 1st lane, containing the lysate directly after sonnication, is rich in protein at all 
molecular weights.  The second lane, containing the load of the lysate onto the nickel 
column contains mostly high molecular weights impurities.  The 3rd lane, which is the 
low imidazole wash, contains several impurities at low concentration.  The 4th lane is a 
broad range molecular weight standard, and the 5th lane is the wash with the high 
imidazole buffer, this lane contains ~99% his-tagged CheY as compared to molecular 
weights in the standard. 
 Digestion of his-tagged CheY is also monitored by SDS-PAGE time trials until 
completion.  Figure 5 shows an SDS-PAGE gel of a thrombin digestion.  Here Lane 1 is 
CheY before digestion as taken off the nickel column.  Lane 2 represents a 15 minute 
timepoint; from this point on 3 bands will be present; the first highest molecular weight 
band represents his-tagged CheY, the second band represents non his-tagged CheY, and 
the third band represents the his-tag.  Lane 3 is a 30 minute timepoint, again, notice that 
the his-tagged CheY band is getting weaker when comparing to the non his-tagged band.  
Lane 3 is a broad range standard.  Lane 5 is a 1-hour timepoint, lane 6 a 2-hour timepoint, 
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lane 7 an 8-hour timepoint, lane 8 a 16-hour timepoint, and lane 9 a 24-hour time point 
where we have essentially all non his-tagged CheY. 
Digested CheY is passed through a Sephadex G-50 column and fractions are 
collected and monitored via A280.  A plot of the fraction number vs. the A280 of the 
fractions yields 3 peaks corresponding to thrombin, CheY, and his-tag respectively 
(Figure 6).  Pooled CheY is analyzed by RP-HPLC and a single peak is desirable (Figure 
7) though sometimes a second peak ~3 minutes before the main peak is present.  Addition 
of 1 mM DTT to the protein with the second peak causes the peak to disappear, 
consistent with the peak representing oxidized CheY (Figure 8).  
 Leupeptin and pepstatin (1 µM), along with the presence of 1 mM PMSF (except 
during thrombin digestion) and 25 mM 2-mercaptoethanol throughout preparation of 
CheY are crucial for phosphono-CheY purification.  Preparations not containing these 
steps have been unable to produce pure phosphono-CheY.  This will be discussed further 
in the modification of CheY section. 
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Figure 4.  SDS-PAGE of fractions from the Ni2+-NTA column.   
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Figure. 5. SDS-PAGE of thrombin digestion timetrials.   
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Figure 6. Peaks recorded from Sephadex G-50 size exclusion column.  
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Figure 7.  RP-HPLC chromatogram of unmodified CheY after his-tag removal 
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Figure 8. a.) RP-HPLC chromatogram of CheY which is presumed to be slightly oxidized.  b.)  RP-HPLC 
chromatogram of the same CheY aliquot with the addition of 10 mM DTT. 
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Production of Phosphono-CheY from thermotoga maritima D54C/C81S CheY 
 When modifying CheY, two important criteria are present; one being the percent 
conversion of CheY to phosphono-CheY, and the other being protein recovery.  A variety 
of conditions were tested in order for optimal results to be achieved; those methods will 
be explained below.  Factors which pertain to alkylation variation are CheY preparation 
conditions (mentioned above), buffer choice, base used, and modification agent used. 
  Optimal alkylation conditions involve the following method.  An aliquot of 
protein containing ~6.5 mg of CheY is taken out and defrosted about 30 minutes prior to 
buffer exchange.  A DTNB assay is performed on the protein to ensure proper reduction, 
75% or greater is recommended; Figure 9 shows a typical DTNB graph.  The amount of 
free thiol is calculated using the equation below: 
(ΔA/ ε410)(13500 gmu)(x mL/1.0x mL) 
In this equation ε410 = 14150 cm-1M-1 , 13500 is the molecular weight of CheY, 
and x is the amount of protein used in the assay.  When the amount of free thiol is 
calculated by using the equation above, it is divided by the total amount of protein 
(obtained by UV scan or Bradford/BCA assay) to obtain a percent of free thiol. 
   After DTNB reaction, CheY is alkylated consistent with methods mentioned in 
the experimental section.  This method of alkylation yields 45-70% conversion of CheY 
to P-CheY as based on DTNB and RP-HPLC while maintaining protein recovery (~5.5 
mg recovered out of 6.5 mg at the start).  Figure 10 shows a DTNB assay after alkylation, 
and Figure 11 shows RP-HPLC chromatogram of a typical alkylation from these 
conditions.  Notice the ∆A of the protein after alkylation is less than before modification 
due to phosphonomethylation of cysteine. 
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Protein Modification Preparation Dependency 
As mentioned above, phosphono-CheY from different preparations of CheY did 
not always purify via cation exchange HPLC.  Comparisons of preparations G and H to 
preparations C and I show a difference in phosphono-CheY quality upon purification.  
The differences in these two preparations are as follows: preparations G and H did not 
contain 1 µM Leupeptin and Pepstatin, nor did they contain 1 mM PMSF and 25 mM 2-
mercaptoethanol throughout the preparation, while preparations C and I did.  Not one 
factor can be pointed out as the key to the preparation success, but it should be noted that 
these conditions should always be employed.  RP-HPLC chromatograms of alkylations 
from these different preparations look virtually identical (under the same alkylation 
conditions) (Figure 12), however, upon purification via cation exchange HPLC 
(discussed in the next section), a difference is seen (Figure 13).  It also should be noted 
that while success in purification is consistent in “good” preparations, percent conversion 
of CheY to phosphono-CheY can be affected.  Alkylations of preparation C for instance 
gave conversion on the order of 80-85%, while alkylation using the same conditions on 
protein from preparation I gave conversion on the order of 45-60%. (Figure 14). 
Buffer/pH Choice for Modification 
Buffer/pH choice is important for at least two reasons; the cysteine residue on the 
protein needs to be in the correct protonation state (R-S- vs. R-SH) for optimal 
modification, but pH must also stay safely away from the pI of the protein to avoid 
possible precipitation.  Since the pKa of cysteine is different in a protein than it would be 
free (pKa = 8.3), an exact value is not know.  Since this is the case, a range of pH values 
was tested against the protein; pH values of 8.0-9.50 were tested.  All buffers were 250 
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mM, TAPS was used from 8.00-9.00, whereas AMPSO was used from 9.00-9.50.  
Alkylations at different pH values looked very similar in RP-HPLC analysis under 
otherwise exact conditions (Figure 15); however, there was one major difference, protein 
recovery was substantially lower at higher pH.  Alkylation of a 6.5 mg aliquot at pH 9.25 
would yield ~2.5 mg of protein (CheY and P-CheY together) after buffer exchange, while 
alkylation of a 6.5 mg aliquot at pH 8.25 would yield ~5.5 mg of protein after buffer 
exchange.  Also noticeable at higher pH values was the large amount of precipitation 
seen after the addition of the PMT/EtOH/Et3N mixture.  This is most likely due to M2+- 
hydroxymethylphosphonate coming out of solution as solubility of the metal ion gets 
lower at higher pH values.  As the buffer pH is lowered, less precipitation is seen after 
addition of the above PMT mixture, with virtually none at pH 8.25. 
Metal Ion and Alkylation 
Three metals were commonly employed during alkylation; Ca2+, Ba2+, and Sr2+.  
As mentioned above, Ca2+ gave the most consistent results during alkylation.  Sr2+ and 
Ba2+ have both worked successfully, yet would sometimes yield a chromatogram of high 
heterogeneity, (Figure 16); the reason for this is unknown.  That particular example was 
one aliquot of CheY split into three 250 μL reactions; all other conditions were kept 
constant.  Other metals ions are discussed in Appendix B 
Protein Modification Agents Used 
Though PMT has been successful in modification of both E. coli and T. maritima 
CheY, other modification agents were tested against T. maritima to see if yield of 
phosphono-CheY could be increased.  Three other modification agents used were the 
tresylate (triflouroethanesulfonate) homolog of PMT (phosphonomethyltresylate), 
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phosphonomethylpentaflourobenzene (PMFB), and phosphonomethyltrichlorosulfonate; 
the structure of these compounds can be seen in Figure 17.  These molecules all contain 
the desired phosphonomethyl group, but contain different leaving groups as to vary the 
reactivity of the phosphonomethylation reaction.  The first two molecules have been used 
successfully to modify a cysteine residue on VHR phosphatase, so there was reason to 
believe they would work in this case.  Upon alkylation with these reagents, the protein 
precipitated completely out of solution.  A possibility is that these reagents were not 
stable at the pH of CheY modification.  If so, the molecules could have precipitated from 
solution while subsequently decreasing pH, causing CheY to precipitate.  Reaction with 
phosphonomethyltrichloromethanesulfonate was more successful than the previous two 
reagents, however, was not advantageous over PMT.  Figure 18 shows RP-HPLC 
chromatograms of timepoints taken during this reaction.  The reaction was performed in 
TAPS pH = 8.25, 125 mM CaCl2 and 3.0 equivalents of Et3N.  Initially the reaction 
looked favorable, but started to become worse as time went on.  The one minute 
timepoint contained very little phosphono-CheY, while the 10 minute timepoint began to 
look favorable with ~35% conversion so far.  The 30 minute timepoint contained a large 
peak with a retention time consistent with phosphono-CheY, but was very broad with 
several side peaks.  By the end of the reaction at a 1 hour timepoint, protein did not retain 
on the column.  The cause for the results seen on the 1 hour timepoint could be 
overmodification or denaturation of the protein. 
Other methods employed in alkylation which were not exhausted and have only 
brief data can be seen in Appendix D. 
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Figure 9.  DTNB assay of CheY.  The absorbance at 410 nm is monitored over a 40 minute period 
as the DTNB reacts with the –SH group of cysteine. 
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Figure 10.  DTNB assay of CheY after phosphonomethylation.  The change in absorbance here is lower 
than the previous DTNB due to less free thiol content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
min10 15 20 25 30 35 40 45 50
mAU
0
2
4
6
8
10
12
14
 DAD1 A, Sig=215,4 Ref =600,100 (F:\BOTTONE\TMY00356.D)
  A
rea
: 1
17
2.0
4
 3
2.
84
0
  A
rea
: 9
36
.17
2
 5
0.
24
8
min10 15 20 25 30 35 40 45 50
mAU
1.15
1.2
1.25
1.3
1.35
1.4
1.45
 DAD1 B, Sig=280,4 Ref =600,100 (F:\BOTTONE\TMY00356.D)
Figure 11.  RP-HPLC chromatogram of a high yield/high purity alkylation.  The 32 minute peak represents 
phosphono-CheY, and the 50 minute peak unmodified CheY.  
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B. 
Figure 12.  a.) RP-HPLC chromatograms of alkylations from A) Preparation H and b.) Preparation I.  The 
gradients of these two are slightly different, explaining the slight difference in retention time.  
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B.  
Figure 13.  a.) RP-HPLC analysis of purified phosphono-CheY from the alkylation shown in Figure 10a.  
b.) RP-HPLC analysis of purified phosphono-CheY from the alkylation shown in Figure 10b.  These two 
were purified via the same sodium acetate cation exchange (will be described in the next section). 
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B.  
Figure 14. a.) RP-HPLC analysis of a typical alkylation from preparation C.  b.) RP-HPLC analysis of a 
typical alkylation from preparation I.  These alkylations were done under the same alkylations conditions 
(250 mM TAPS pH = 8.25, 120 mM PMT, 125 mM Ca2+). 
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C. 
Figure 15. RP-HPLC analysis of  a.) Alkylation of pool I at pH = 8.0.  b.) alkylation of pool I at pH = 8.25.  
c.) alkylation of pool I at pH = 9.25. 
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C.  
Figure 16.  RP-HPLC analysis of a single aliquot of CheY from preparation I separated into 3 reactions.   
a.) Alkylation containing 125 mM Sr2+.  b.) Alkylation containing 125 mM Ba2+.   c.) Alkylation containing 
125 mM Ca2+. 
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Figure 17.  Structures of  a.) Phosphonomethylpentaflourobenzenesulfonate and b.) 
Phosphonomethyltriflouroethanesulfonate. 
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D. 
Figure 18.  RP-HPLC chromatograms of CheY modification with phosphonomethyltrichlorosulfonate.  a.) 
1 minute timepoint. b.) 10 minute timepoint. c.) 30 minute timepoint.  d.) 1 hour timepoint. 
 
 
40 
Purification of Phosphono-CheY via Cation-Exchange HPLC (CEX-HPLC) 
 Due to the substantial change in charge of CheY upon addition of the 
phosphonomethyl group, CEX- HPLC seemed to be a suitable purification tool.  Because 
our protein is positively charged, (theoretical pI = 8.68) cation, rather than anion 
exchange was desirable.  Mobile phases with varying salts, salt concentrations, and pH 
values were tested against CheY.  All peaks were collected and re-analyzed via RP-
HPLC to check the purity of the cation exchange peaks.  Development of the final 
gradient came about after several initial conditions were tested.  The preferred method of 
purification is discussed first, followed by other methods which led up to the final 
method. 
The system that gave both optimal separation and highest recovery of protein was 
composed of a 50 mM acetate buffer at a pH = 5.3; the gradient ran from 0 to 11.7% 
MPB over 47 minutes.  Injection of an alkylation (Figure 19) gave us a chromatogram 
composed of two major peaks and several smaller peaks (Figure 20.).  Upon analysis of 
the first cation exchange peak onto RP-HPLC, a single peak corresponding to 
phosphono-CheY was observed (Figure 21).  5.5 mg of protein typically gave us about 
700 µg of phosphono-CheY in return.  Since most of our alkylations showed 50% 
conversion to phosphono-CheY according to RP-HPLC, and a standard injection was 
~5.5 mg, this number seems low, yet has given us the highest recovery out of all the other 
methods used. 
 Initially, a 10 mM potassium phosphate buffer (pH = 6.8) was used. CheY was 
buffer exchanged into MPA and run on a gradient which went from 0 to 30% MPB over 
40 minutes.  An alkylation from preparation C (figure 22) was buffer exchanged into 
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MPA and run over the same gradient.  The resulting chromatogram (figure 22) showed 
three main peaks with some other minor shoulders and peaks. Each peak was collected 
and concentrated down to a reasonable concentration, usually ~2-3 mg/mL, and run on 
RP-HPLC for analysis.  Reinjection of the 1st CEX-HPLC peak gave one main peak at 29 
minutes (figure 23) which is consistent with phosphono-CheY, and one minor peak at 47 
minutes corresponding to unmodified CheY.  Reinjection of the 2nd peak, which was a 
double peaked species at 13.5 and 14 minutes, gave a mixture of mostly unmodified 
CheY with a peak a few minutes earlier, possibly oxidized CheY (figure 24).  Reinjection 
of the 3rd peak at 16 minutes (figure 25) gave two species as well, one consistent with 
unmodified CheY and the other ~4 minutes earlier, consistent with possible oxidized 
CheY.  Besides lack of resolution, this method seemed to have two major flaws, the yield 
from the column was very low, and optimal purity was not achieved, as CheY was still 
present at ~20%.  A single injection of an alkylation containing ~5.5 mg of protein would 
typically only yield in about 700 µg total protein in return, with only about 100 µg being 
P-CheY.  It is believed that the ionic strength of the buffer was too low for the protein to 
remain in solution.  Also, precipitation became a problem when metal plus protein 
solution was in phosphate; we believe the phosphate buffer acted as a chelation agent for 
the metal and therefore pulled everything out of solution. 
 Because higher salt was needed, as well as a new buffer salt, the solvent system 
was switched to a 25 mM sodium acetate buffer with a pH = 5.0; the gradient ran from 0 
to 15% MPB over 30 minutes.  Because the pH is lower than in the phosphate buffer, the 
protein should stick more tightly to the column, thus require a higher concentration of salt 
to elute the protein.  Upon injection of a CheY alkylation (Figure 26a), this was found to 
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be true (Figure 26b).  Here the protein came out in a higher salt concentration than it did 
in the phosphate buffer.  One must remember to take into account both the ionic strength 
of the salt (NaCl) and the buffer itself, which had a higher initial concentration in this 
method (25 mM vs. 10 mM).  The method gave a chromatogram with two main peaks 
with sufficient resolution (Figure 26b).  A problem however arose when reinjection of the 
first CEX peak onto RP-HPLC gave a double peak, one representing phosphono-CheY 
and one representing CheY (Figure 27); analysis of the 2nd peak in the chromatogram 
looked nearly identical (Figure 28).  With this method however, the yield of total protein 
did go up, with about 60% of total protein recovered. 
 Although the 25 mM acetate gradient gave a clean looking chromatogram with 
sufficient resolution, a new method was sought because of incomplete purification and 
protein recovery that was still less than desirable.  The new gradient developed was one 
consisting of 25 mM MES buffer at pH = 5.8.  The gradient was run from 0 to 16% MPB 
over 30 minutes.  Figure 29 shows chromatograms of both RP-HPLC analysis of an 
alkylation mixture as well as its subsequent CEX-HPLC chromatogram using this 
method.  Like the phosphate method, 3 main peaks are seen, and each of these was 
analyzed via RP-HPLC.  The first peak at 21 minutes (Figure 30) showed mainly 
phosphono-CheY, but still had ~10% CheY present.  Peak 2 at 23 minutes (Figure 31) 
was fairly messy and showed 3 main peaks.  The only peak which can be positively 
identified is the 3rd peak, which corresponds with unmodified CheY; the possibilities of 
the other two are oxidized and/or denatured protein.  Analysis of the 3rd peak at 27 
minutes (Figure 32) showed two main species, corresponding with phosphono-CheY and 
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unmodified CheY.  Although this method gave fairly pure phosphono-CheY, greater 
purity was needed; that, plus the expense of MES, gave need to develop another method. 
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Figure 19.  RP-HPLC chromatogram of an alkylation, this alkylation is both high in purity and in yield. The 
12 minute is presumed doubly modified CheY, the 28 minute peak is P-CheY, and the 44 minute peak is 
unmodified CheY.  
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Figure 20.  Cation exchange HPLC chromatogram of alkylation seen in Figure 19 using 50 mM sodium 
acetate pH = 5.3 with a gradient going from 0 to 11.7% MPB over 47 minutes. 
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Figure 21.  RP-HPLC chromatogram of the 1st cation exchange peak from the 50 mM sodium acetate 
method.  It is a single peak representative of phosphono-CheY. 
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Figure 22.  CEX-HPLC chromatogram of the previous alkylation.  The gradient run was 0 to 30% MPB 
over 30 minutes.  MPA was 10 mM potassium phosphate, pH = 6.2, and MPB was 10 mM potassium 
phosphate plus 500 mM NaCl, pH = 6.2.   
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Figure 23.  RP-HPLC analysis of the 1st peak in the cation exchange chromatogram shown in Figure 22.  
The major peak here corresponds with phosphono-CheY; however, there is some CheY still present. 
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Figure 24.  RP-HPLC analysis of the 2nd peak in the cation exchange chromatogram shown in Figure 22.  
The major peak here corresponds with unmodified CheY. 
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Figure 25.  RP-HPLC analysis of the 3rd peak in the cation exchange chromatogram shown in Figure 22.  
The major peak here corresponds with unmodified CheY. 
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B. 
Figure 26.  a.) RP-HPLC chromatogram of alkylation from preparation H.  b.) CEX chromatogram of the 
same alkylation using a 25 mM sodium acetate buffer at pH = 5.0. 
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Figure 27.  RP-HPLC chromatogram of the 1st cation exchange peak at 17.2 minutes from Figure 26.  The 
main species is phosphono-CheY; however, The CheY peak at 37 minutes is still present in about ~45%. 
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Figure 28.  RP-HPLC chromatogram of the 2nd peak in the cation exchange chromatogram shown in Figure 
26. 
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B. 
Figure 29.  a.) RP-HPLC chromatogram of an alkylation from preparation C.  b.) Cation exchange HPLC 
chromatogram of the same alkylation on a 25 mM MES gradient pH = 5.8. 
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Figure 30.  RP-HPLC chromatogram of the 21 minute CEX peak seen in Figure 29.  Here there is one 
major species corresponding to phosphono-CheY, with a little small amount of CheY still present. 
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Figure 31.  RP-HPLC chromatogram of the 23 minute CEX peak seen in Figure 29.  Here there is one 
major species corresponding to unmodified CheY.  Several other peaks are present as well but their identity 
is only speculative; oxidized and denatured proteins are possibilities. 
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Figure 32.  RP-HPLC chromatogram of the 27 minute CEX peak seen in Figure 29.  Here there is one 
major species corresponding to unmodified CheY and another corresponding to phosphono-CheY. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
Crystallization of Phosphono-CheY from T. maritima  
 Once a reasonable amount of pure phosphono-CheY was obtained via CEX-
HPLC, two crystallization screens were setup.  These screens were based on conditions 
that had worked for E. coli phosphono-CheY and for wild type CheY from T. maritima.  
Tables 1 and 2 show the conditions used for the two screens (Note that MgCl2 is used 
because a crystal structure of the magnesium complex of phosphono-CheY is desirable). 
While all wells produced crystals of some sort, only a few produced crystals which might 
be large enough to diffract X-rays.  Tables 3-8 show the results of the crystallization trials 
after a 1 month period, 3 month period, and 5 month period respectively.  Wells typically 
produced one of seven different results, these being the following: clear drops, phase 
separation, needles, rosettes, single crystals of 0.2 mm or less which were either scattered 
throughout the drop or centrally “clumped” together, or single crystals of 0.2 mm or 
greater.  The tables mentioned above summarize these results.  Desirable crystals are 
those which are a single crystal of 0.2 mm or greater.  Other crystals, such as needles and 
single or clustered crystals of 0.2 mm or less are usually the result of only a minor issue 
such as the percentage of PEG present or a minor pH issue (off in pH in the order of only 
a few tenths of a pH unit).  The least desirable of these is a clear drop, in which nothing 
forms.  Phase separation (Figure 33) is an amorphous stage in which crystallization may 
or may not occur in the future.  Needles are one-dimensional growth in which the crystal 
grows in one direction and very little in the other dimensions (Figure 34).  The rosettes 
were small star like structures (Figure 35) which if bigger, would have been possible 
candidates for X-ray diffraction; the same can be said of the spherulites, only they are 
more “weblike” in appearance.  A large majority of the crystals came in the form of a 
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small (<0.1 mm) “x” shape; there were usually very many of these scattered throughout a 
drop (Figure 36).  In some cases small rectangular crystals were seen bunched together in 
the middle of the drop (Figure 37).  Though these crystals would not be suitable for X-ray 
diffraction, they are a promising result, as crystallization screens can be focused around 
those particular conditions. They may also be good candidates for gel electrophoresis.  
These crystals can be washed and dissolved for use on native or SDS PAGE as 
demonstrated by Michael Harrington and Lindsey Boroughs (unpublished results).  
Several larger crystals (>0.2 mm) (examples seen in Figures 38 and 39) which are high 
candidates for crystallography were also seen.  The four larger crystals produced were 
shaped differently, as two of them were less rigid looking than the other; however, it is 
impossible to judge whether or not a “pretty” or “ugly” crystal will give suitable 
diffraction without actually shooting it.  The conditions that gave these larger crystals 
were quite different, which might be the cause of their differences.  The nicer looking 
crystals were both produced in PEG 3400 with one being in HEPES pH = 7.0 and the 
other in acetate pH = 4.5; their PEG concentrations were 26% and 28% respectively.  
Interestingly, the less attractive looking crystals were produced under the same 
conditions, only in PEG 4000.   
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A1  100 mM Acetate(4.5)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B1  100 mM PIPES(6.5)     
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C1  100 mM HEPES(7.0)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D1  100 mM Tris(8.5)       
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A2  100 mM Acetate(4.5)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B2  100 mM PIPES(6.5)     
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C2  100 mM HEPES(7.0)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D2  100 mM Tris(8.5)       
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A3  100 mM Acetate(4.5)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B 3 100 mM PIPES(6.5)     
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C3  100 mM HEPES(7.0)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D3  100 mM Tris(8.5)       
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A4  100 mM Acetate(4.5)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B4 100 mM PIPES(6.5)      
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C4  100 mM HEPES(7.0)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D4  100 mM Tris(8.5)       
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A5  100 mM Acetate(4.5)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B5  100 mM PIPES(6.5)     
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C5  100 mM HEPES(7.0)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D5  100 mM Tris(8.5)       
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A6  100 mM Acetate(4.5)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B6  100 mM PIPES(6.5)     
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C6  100 mM HEPES(7.0)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D6  100 mM Tris(8.5)       
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
Table 1.  P-CheY crystal screen I.  This tray screened using four different pH values as well as 6 different 
PEG 4000 concentrations.  Ammonium sulphate and magnesium chloride were held constant throughout. 
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A1  100 mM Acetate(4.5)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B1  100 mM PIPES(6.5)     
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C1  100 mM HEPES(7.0)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D1  100 mM Tris(8.5)       
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A2  100 mM Acetate(4.5)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B2  100 mM PIPES(6.5)     
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C2  100 mM HEPES(7.0)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D2  100 mM Tris(8.5)       
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A3  100 mM Acetate(4.5)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B 3 100 mM PIPES(6.5)     
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C3  100 mM HEPES(7.0)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D3  100 mM Tris(8.5)       
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A4  100 mM Acetate(4.5)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B4 100 mM PIPES(6.5)      
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C4  100 mM HEPES(7.0)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D4  100 mM Tris(8.5)       
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A5  100 mM Acetate(4.5)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B5  100 mM PIPES(6.5)     
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C5  100 mM HEPES(7.0)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D5  100 mM Tris(8.5)       
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
A6  100 mM Acetate(4.5)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
B6  100 mM PIPES(6.5)     
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
C6  100 mM HEPES(7.0)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
D6  100 mM Tris(8.5)       
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 
Table 2.  P-CheY crystal screen II.  This tray screened using four different pH values as well as 6 different 
PEG 3400 concentrations.  Ammonium sulphate and magnesium chloride were held constant throughout. 
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A1  100 mM Acetate(4.5)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
 
B1  100 mM PIPES(6.5)     
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C1  100 mM HEPES(7.0)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D1  100 mM Tris(8.5)       
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A2  100 mM Acetate(4.5)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
B2  100 mM PIPES(6.5)     
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
C2  100 mM HEPES(7.0)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
D2  100 mM Tris(8.5)       
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A3  100 mM Acetate(4.5)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
B 3 100 mM PIPES(6.5)     
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C3  100 mM HEPES(7.0)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D3  100 mM Tris(8.5)       
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
A4  100 mM Acetate(4.5)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
B4 100 mM PIPES(6.5)      
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
C4  100 mM HEPES(7.0)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D4  100 mM Tris(8.5)       
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A5  100 mM Acetate(4.5)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 – 7 
B5  100 mM PIPES(6.5)     
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C5  100 mM HEPES(7.0)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D5  100 mM Tris(8.5)       
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A6  100 mM Acetate(4.5)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
B6  100 mM PIPES(6.5)     
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C6  100 mM HEPES(7.0)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 7 
D6  100 mM Tris(8.5)       
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
1 – Clear Drop 
2 – Phase Separation 
3 – Rosettes or Spherulites 
4 – Needles (1D Growth) 
5 – Single Crystals (3D Growth <0.2 mm) scattered throughout 
6 – Single Crystals (3D Growth <0.2 mm) clumped centrally 
7 – Single Crystals (3D Growth >0.2 mm) 
Table 3 . P-CheY crystal screen I results after 1 month. 
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A1  100 mM Acetate(4.5)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
 
B1  100 mM PIPES(6.5)     
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C1  100 mM HEPES(7.0)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D1  100 mM Tris(8.5)       
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A2  100 mM Acetate(4.5)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
B2  100 mM PIPES(6.5)     
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
C2  100 mM HEPES(7.0)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
D2  100 mM Tris(8.5)       
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A3  100 mM Acetate(4.5)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
B 3 100 mM PIPES(6.5)     
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C3  100 mM HEPES(7.0)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D3  100 mM Tris(8.5)       
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
A4  100 mM Acetate(4.5)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
B4 100 mM PIPES(6.5)      
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
C4  100 mM HEPES(7.0)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D4  100 mM Tris(8.5)       
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A5  100 mM Acetate(4.5)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 – 7 
B5  100 mM PIPES(6.5)     
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C5  100 mM HEPES(7.0)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D5  100 mM Tris(8.5)       
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A6  100 mM Acetate(4.5)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
B6  100 mM PIPES(6.5)     
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C6  100 mM HEPES(7.0)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 7 
D6  100 mM Tris(8.5)       
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
1 – Clear Drop 
2 – Phase Separation 
3 – Rosettes or Spherulites 
4 – Needles (1D Growth) 
5 – Single Crystals (3D Growth <0.2 mm) scattered throughout 
6 – Single Crystals (3D Growth <0.2 mm) clumped centrally 
7 – Single Crystals (3D Growth >0.2 mm) 
Table 4 . P-CheY crystal screen II results after 1 month. 
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A1  100 mM Acetate(4.5)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3/4 
 
B1  100 mM PIPES(6.5)     
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C1  100 mM HEPES(7.0)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D1  100 mM Tris(8.5)       
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
A2  100 mM Acetate(4.5)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
B2  100 mM PIPES(6.5)     
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
C2  100 mM HEPES(7.0)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D2  100 mM Tris(8.5)       
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
A3  100 mM Acetate(4.5)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 4 
B 3 100 mM PIPES(6.5)     
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C3  100 mM HEPES(7.0)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D3  100 mM Tris(8.5)       
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
A4  100 mM Acetate(4.5)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
B4 100 mM PIPES(6.5)      
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C4  100 mM HEPES(7.0)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D4  100 mM Tris(8.5)       
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
A5  100 mM Acetate(4.5)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 – 7 
B5  100 mM PIPES(6.5)     
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C5  100 mM HEPES(7.0)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D5  100 mM Tris(8.5)       
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
A6  100 mM Acetate(4.5)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 7 
B6  100 mM PIPES(6.5)     
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C6  100 mM HEPES(7.0)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D6  100 mM Tris(8.5)       
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
1 – Clear Drop 
2 – Phase Separation 
3 – Rosettes or Spherulites 
4 – Needles (1D Growth) 
5 – Single Crystals (3D Growth <0.2 mm) scattered throughout 
6 – Single Crystals (3D Growth <0.2 mm) clumped centrally 
7 – Single Crystals (3D Growth >0.2 mm) 
Table 5 . P-CheY crystal screen I results after 3 months. 
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A1  100 mM Acetate(4.5)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 4 
 
B1  100 mM PIPES(6.5)     
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C1  100 mM HEPES(7.0)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D1  100 mM Tris(8.5)       
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A2  100 mM Acetate(4.5)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - * 
B2  100 mM PIPES(6.5)     
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
C2  100 mM HEPES(7.0)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D2  100 mM Tris(8.5)       
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A3  100 mM Acetate(4.5)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
B 3 100 mM PIPES(6.5)     
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
C3  100 mM HEPES(7.0)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D3  100 mM Tris(8.5)       
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
A4  100 mM Acetate(4.5)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
B4 100 mM PIPES(6.5)      
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C4  100 mM HEPES(7.0)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D4  100 mM Tris(8.5)       
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
A5  100 mM Acetate(4.5)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
B5  100 mM PIPES(6.5)     
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C5  100 mM HEPES(7.0)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D5  100 mM Tris(8.5)       
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A6  100 mM Acetate(4.5)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 7 
B6  100 mM PIPES(6.5)     
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C6  100 mM HEPES(7.0)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 7 
D6  100 mM Tris(8.5)       
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
1 – Clear Drop 
2 – Phase Separation 
3 – Rosettes or Spherulites 
4 – Needles (1D Growth) 
5 – Single Crystals (3D Growth <0.2 mm) scattered throughout 
6 – Single Crystals (3D Growth <0.2 mm) clumped centrally 
7 – Single Crystals (3D Growth >0.2 mm) 
* - Broken Coverslip 
Table 6 . P-CheY crystal screen II results after 3 month. 
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A1  100 mM Acetate(4.5)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
 
B1  100 mM PIPES(6.5)     
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C1  100 mM HEPES(7.0)   
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D1  100 mM Tris(8.5)       
        PEG 4000, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A2  100 mM Acetate(4.5)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
B2  100 mM PIPES(6.5)     
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
C2  100 mM HEPES(7.0)   
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
D2  100 mM Tris(8.5)       
        PEG 4000, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A3  100 mM Acetate(4.5)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
B 3 100 mM PIPES(6.5)     
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C3  100 mM HEPES(7.0)   
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D3  100 mM Tris(8.5)       
        PEG 4000, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
A4  100 mM Acetate(4.5)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
B4 100 mM PIPES(6.5)      
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
C4  100 mM HEPES(7.0)   
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D4  100 mM Tris(8.5)       
        PEG 4000, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A5  100 mM Acetate(4.5)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 – 7 
B5  100 mM PIPES(6.5)     
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C5  100 mM HEPES(7.0)   
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D5  100 mM Tris(8.5)       
        PEG 4000, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A6  100 mM Acetate(4.5)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
B6  100 mM PIPES(6.5)     
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C6  100 mM HEPES(7.0)   
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 7 
D6  100 mM Tris(8.5)       
        PEG 4000, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
1 – Clear Drop 
2 – Phase Separation 
3 – Rosettes or Spherulites 
4 – Needles (1D Growth) 
5 – Single Crystals (3D Growth <0.2 mm) scattered throughout 
6 – Single Crystals (3D Growth <0.2 mm) clumped centrally 
7 – Single Crystals (3D Growth >0.2 mm) 
Table 7 . P-CheY crystal screen I results after 5 months. 
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A1  100 mM Acetate(4.5)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
 
B1  100 mM PIPES(6.5)     
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C1  100 mM HEPES(7.0)   
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
D1  100 mM Tris(8.5)       
        PEG 3400, 36% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A2  100 mM Acetate(4.5)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 1 
B2  100 mM PIPES(6.5)     
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
C2  100 mM HEPES(7.0)   
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
D2  100 mM Tris(8.5)       
        PEG 3400, 34% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A3  100 mM Acetate(4.5)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
B 3 100 mM PIPES(6.5)     
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C3  100 mM HEPES(7.0)   
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D3  100 mM Tris(8.5)       
        PEG 3400, 32% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
A4  100 mM Acetate(4.5)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
B4 100 mM PIPES(6.5)      
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 2/5 
C4  100 mM HEPES(7.0)   
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D4  100 mM Tris(8.5)       
        PEG 3400, 30% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
A5  100 mM Acetate(4.5)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 – 7 
B5  100 mM PIPES(6.5)     
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C5  100 mM HEPES(7.0)   
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 6 
D5  100 mM Tris(8.5)       
        PEG 3400, 28% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
A6  100 mM Acetate(4.5)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
B6  100 mM PIPES(6.5)     
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 5 
C6  100 mM HEPES(7.0)   
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 7 
D6  100 mM Tris(8.5)       
        PEG 3400, 26% 
       .2 M (NH4)SO4 
       15 mM MgCl2 - 3 
1 – Clear Drop 
2 – Phase Separation 
3 – Rosettes or Spherulites 
4 – Needles (1D Growth) 
5 – Single Crystals (3D Growth <0.2 mm) scattered throughout 
6 – Single Crystals (3D Growth <0.2 mm) clumped centrally 
7 – Single Crystals (3D Growth >0.2 mm) 
Table 8 . P-CheY crystal screen II results after 5 month. 
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Figure 33.  Picture of a crystallization drop showing phase separation. 
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Figure 34.  Picture of a crystallization drop showing phase spherulletes. 
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Figure 35.  Picture of a crystallization drop showing needles. 
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Figure 36.  Picture of a crystallization drop showing crystals which are <0.2 mm and scattered throughout 
the drop. 
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Figure 37.  Picture of a crystallization drop showing crystals which are <0.2 mm and clumped centrally in 
the drop. 
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Figure 38.  Picture of a crystallization drop showing a single crystal which is >0.2 mm. 
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Figure 39.  Picture of a crystallization drop showing a single crystal >0.2 mm in size. 
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Synthesis of Phosphonomethyltrichlorosulfonate 
 
 As sulfinate ester was formed the solution began to turn orange in color and 
precipitate slightly.  The reaction also gave off gas during the dripping in of the 
trichlorosulfinylchloride. Following the reaction NMR samples are made up of 5 µL of 
sample and brought up to ~500 µL with CDCl3.  Figure 40 shows the 1H NMR spectra of 
the starting dibenzyl-HMP and Figure 41 the 1H NMR of the sulfinylation product along 
with their peak assignments.  The starting material contains 3 different sets of protons; 
the aromatic, the benzylic, and the ones next the –OH group.  The triplet at ~3.9 ppm 
represents the CH2 protons next to phosphorus.  Since phosphorus is NMR active, those 
protons will couple with phosphorus.  The multiplet at 5 ppm arises from benzyl protons, 
and the large peak at ~7.4 ppm is the aromatic region.  The changes in the sulfinate ester 
arise from two factors, one being the stronger electron withdrawing effects contained 
within the trichlorosulfonate group, and the other arising from the introduction of a 
stereogenic center at the sulfur atom.  The stereocenter causes the CH2 protons to become 
diastereotopic.  Diastereotopic protons are not magnetically equivalent therefore will not 
couple equally with neighboring molecules.  Because of this, an ABX pattern is seen in 
the spectra.  A slightly downfield shift is seen in the CH2 protons which are now spread 
out between 4.1-4.7 ppm.  The benzylic and aromatic protons are unaffected as they are 
too far away to feel any electron withdrawing effects.   
 If sulfination is successful, oxidation is carried out.  Typically the oxidation 
reaction will turn dark green and some precipitate will form, the resulting product is a 
syrupy light green substance.  ~5 µL is taken for an NMR sample and added to ~450 µL 
CDCl3.  The 1H NMR spectra of the sulfonation reaction can be seen in Figure 42.  The 
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major difference in the spectra of the sulfonation reaction is the absence of the ABX 
pattern.  The doublet which replaces the ABX splitting at 4.56 ppm represents the CH2 
protons next to the oxygen. The doublet appears because the added oxygen on the sulfur 
atom makes the molecule achrial and the two protons are now magnetically equivalent; 
only splitting with phosphorus is seen.  The chemical shifts of the benzylic and aromatic 
protons again are unaffected. 
 The final step in the synthesis is the removal of the benzyl groups; this is done by 
standard catalytic hydrogenation.  The 1H NMR spectra of the compound shows only the 
doublet as the aromatic and benzylic protons are absent (Figure 43).   
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Figure 40.  1H NMR spectra of the starting material, dibenzyl-hydroxymethylphosphonate. 
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Figure 41.  1H NMR spectra of the sulfinylation reaction. 
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Figure 42.  1H NMR spectra of the sulfonylation reaction. 
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Figure 43.  1H NMR spectra of debenzylation reaction. 
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DISCUSSION 
Phosphonomethylation of D54C/C81S CheY from T. maritima 
 Phosphonomethylation was carried out under conditions similar to those used for 
D57C CheY from E. coli.  Because CheY from T. maritima is more sensitive to high 
ionic strength, buffer concentration as well as metal ion concentration was lowered when 
compared to CheY from E. coli.  For best alkylation, D54C/C81S CheY prepared from a 
growth with proper preparation conditions (containing protease inhibitors as previously 
mentioned) will be used; proper reduced (>75%) must also be insured by DTNB assay. 
CheY is alkylated by placing it in a 250 mM TAPS buffer, pH = 8.25 and modifying it 
using 120 mM PMT, and 3.0 equivalents of Et3N; the conversion of CheY to phosphono-
CheY under these conditions averages ~50% by RP-HPLC.  Higher yield was obtained at 
times, with as much as 85%, though these experiments could not be repeated consistently.  
As mentioned earlier, alkylation success varied from preparation to preparation.  A given 
preparation of CheY would give consistent results under the same alkylation conditions, 
however, would not be consistent between one preparation of CheY and another.  For 
example, alkylations on the order of 80% were achieved in prep. C, but alkylations using 
the same conditions only gave conversion on the order of 50% or so in preparation I; 
there are several possible reasons for this.  Though growth conditions are reproduced as 
closely as possible, the exact time between induction (addition of IPTG) of the cells and 
harvesting of them varies quite a bit (this time should be kept constant in the future).  As 
the protocol reads, 4-7 hours is suggested for growth after induction, it might be desirable 
to pick an exact time.  The most obvious answer for this problem is the reduction sate of 
the protein.  Protein reduction might vary from preparation to preparation, thus affecting 
percent conversion.  If the protein is oxidized to an irreversible state such as a sulfonic 
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acid, reducing agents may not be effective.  Although DTNB assay should confirm 
reduction, the assay itself is subject to experimental error.  One factor of error arises from 
the fact that a small amount of reducing agent may be present during the time of the 
assay.  Although a buffer exchange step is employed before the assay, it is not 
unreasonable to expect that a few percent of reducing agent is left behind.  The presence 
of reducing agent will reduce DTNB, therefore causing reduction of the protein to seem 
higher than it actually is.   
Other than percent conversion of CheY to phosphono-CheY, protein loss during 
modification can become a problem.  Loss of protein during modification seems to be the 
same throughout all preparations of CheY. Typically, a reaction containing 6.5 mg of 
CheY will yield < 5.5 mg of protein after alkylation and buffer exchange.  Because the 
loss of protein is so consistent, regardless of preparation, this problem must be assessed 
carefully.  Though the reasons stated herein are presented in order to explain protein loss, 
many of them can also affect the success of the alkylation as was discussed above.  
Because alkylation success varies from preparation to preparation in the first place, it is 
difficult to assess how a change in alkylation conditions in one given preparation will 
affect CheY modification throughout all preparations of CheY. 
First, loss of protein during buffer exchange must be expected, it is not 
uncommon to lose ~5% of one’s protein during buffer exchange over a PD-10 column.  
This, however, is not the major cause of protein loss in this case.  One likely reason for 
protein loss is precipitation due to pH change.  Even though the buffer is supposed to 
resist pH change, the PMT will still drive the pH down a few tenths of a pH unit as 
measured with narrow range pH paper.  When using a buffer with a pH higher than the 
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protein’s pI (8.68), the buffer pH can sometimes fall down just enough to reach the pI of 
the protein, causing CheY to fall out of solution.  If an alkylation is performed below the 
pI of CheY, loss of protein becomes less of a problem; however, is not irrelevant all 
together.  It is possible that upon addition of PMT there is a large change in pH in the 
area where PMT is first introduced, due to a high initial concentration of PMT in the 
reaction before diffusion can occur.  If this is the case, protein could fall out of solution 
due to the sudden pH change.  One concern is the increased amount of precipitation seen 
as the pH of the alkylation buffer is increased.  This precipitate can be deceiving, 
considering metal ion is increasingly insoluble as pH increases.  A large majority of 
precipitate seen in alkylations of pH 9 and above is due to metal precipitation.  One must 
also remember that the pH cannot be lowered too much or the lessened nucleophilicity of 
the cysteine will decrease as we seen in lower pH alkylations (pH = 8.0). 
Another possibility for protein loss arises from the high organic content of the 
reaction.  Organic solvents are commonly used to precipitate proteins out of solution, and 
the organic content of the modification reaction may just be high enough to cause some 
of the protein to come out of solution.  Alkylation using KOH rather than Et3N as a base 
has been employed in the past, however no conclusive results have been made and further 
work should be carried out in that area. 
 The final consideration is the one which is the most difficult to control, that factor 
is technique.  Even though careful consideration is taken to repeat exactly how a reaction 
was performed, it is extremely difficult to be exactly the same every time.  Technique can 
be a factor in how long the PMT/ethanol mixture is left to sit, or how long the PMT and 
Et3N are left together, and most importantly, how fast and efficient the PMT/Et3N 
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mixture is transferred into the protein solution.  It is common for a little bit of the PMT 
mixture to be left behind while transfer is taking place, and it must be added a few 
seconds later after the main PMT mixture is delivered.  Time is especially important 
during this transfer since the PMT hydrolyzed quickly and will degrade in the presence of 
Et3N if left for too long. 
 
Purification of Phosphono-CheY 
 Initially, purification of phosphono-CheY from T. maritima was modeled after 
methods which worked for phosphono-CheY from E. coli.  This method involves 
biotin/avidin chemistry.  Derivatives of biotin such as PEO-Iodoacetyl biotin and PEO-
maleimide biotin are typically reactive toward sulfhydryl groups, like the one on cysteine 
in CheY.  Biotin itself has a high affinity for avidin, which is advantageous in the 
purification step.  When purifying phosphono-CheY from E. coli, one of the above biotin 
derivatives is reacted with the phosphono-CheY/CheY mixture causing any unmodified 
CheY to become biotinylated.  The mixture of the biotinylated CheY and phosphono-
CheY is run over an avidin column to allow biotinylated CheY to bind and phosphono-
CheY to run through, yielding pure phosphono-CheY.  This method was highly 
successful for E. coli CheY but has been mostly a failure with T. maritima CheY.  
Phosphono-CheY from T. maritima has been purified from this method in the past, 
however an extremely low yield was obtained, and several biotinylations were needed.  
Because this method became undesirable, a new method was sought out.   
The idea for ion exchange came about after numerous conversations with Dr. 
Andrew Alpert of PolyLC Inc., and due to prior knowledge of cation exchange use in 
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separation of hemoglobin.  Initial conditions for cation exchange HPLC were suggested 
by him and the recommended buffer was 10 mM K2HPO4 at pH = 6.8 with Na+ used as a 
counter ion in MPB.  The gradient worked out was one which went from 0 to 40% MPB 
over 40 minutes.  Separation and purification using this gradient worked moderately well; 
however, protein recovery was a major issue.  Injection of a 5 mg reaction mixture would 
only give back a 1 mg or so of protein, with only ~150 µg being phosphono-CheY.  Two 
possibilities were possible culprits for protein loss, one being that the ionic strength of the 
buffer was too low, and the other being that phosphate itself pulled the protein out of 
solution.  The first course of action was to raise the ionic strength of the phosphate 
buffer; it was raised to 25 mM and re-run.  At the higher phosphate concentration no 
protein had stuck at all, meaning that if this method was to work a pH change in the 
buffer would have to take place as well.  Because a different pH was needed and a change 
in actual buffer identity was desirable, a 25 mM sodium acetate buffer at pH = 5.0 was 
used.  The gradient used for this buffer ran from 0 to 15% MPB over 30 minutes.  This 
method initially seemed to work much better than the phosphate method as far as 
purification went.  The overall yield from the column was much greater and the 
chromatogram itself looked much cleaner. Since both ionic strength and buffer identity 
was changed from the phosphate system, it’s hard to pinpoint which one of the two was 
the problem.  When reinjection of the first peak gave back two peaks after several runs, 
the quality of this gradient was questioned and the method was abandoned.  In retrospect, 
it is now known that the preparation itself was most likely responsible for this and not the 
method of purification. 
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The following method consisted of 25 mM MES at pH = 5.8, with the gradient 
going from 0 to 16% MPB over 30 minutes.  The MES method came with three main 
problems; cleanliness, expense, and purity, which was later dismissed as a preparation 
problem (pertaining to the absence of leupeptin and pepstatin during the growth).  
Running on this method produced a large baseline drift over time which affected the 
resolution of the peaks, making it sometimes difficult to discern between two different 
peaks.  That, coupled with the amount of buffer which is used in purification (HPLC 
grade MES was expensive and being used at a high rate), made this method somewhat 
undesirable already.   
The main problem with the MES method was the purity of phosphono-CheY 
which eluted from the column.  Purification using this method never produced pure 
phosphono-CheY; however, at the same time this method was being devised, a 
preparation of CheY which did not contain optimal growth conditions was used (no 
Leupeptin, Pepstatin, or PMSF).  At the time, these “bad” preparations were not thought 
about, so the problem in purification likely was because of the preparation itself rather 
than the method used.  Because we didn’t know about preparation dependency, this 
actually became the main reason the method was abandoned. 
Upon further consideration and after another preparation of CheY (containing the 
three protease inhibitors), another acetate system was devised.  Because acetate had given 
the best resolution and cleanest chromatograms in the past, a method with slight 
modification over the previous system was developed in hopes the protein recovery could 
be increased.  The method developed was contained 50 mM sodium acetate at pH = 5.3, 
with the method running from 0 to 11.7% MPB over 47 minutes.  This method gave both 
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better resolution and higher recovery than all the previous systems.  Because higher 
recovery was seen again, the ionic strength hypothesis becomes more valid, as this 
system contained the highest ionic strength of all the systems.  Still though, recovery was 
less than expected.  Theoretically, ~30 mg of phosphono-CheY should be obtained for 
every 100 mg of CheY alkylated.  Based on rough calculations, there is an average of 
40% conversion of CheY to phosphono-CheY, and an estimated 10% loss for steps such 
as buffer exchange and concentration.  Currently, methods to improve recovery are under 
investigation, these include the use of an organic modifier in the cation exchange buffers 
(such as 10% isopropanol), and using a buffer of even higher ionic strength. 
It should also be noted that just because the RP-HPLC and CEX-HPLC 
chromatograms of a particular alkylation are very similar looking as far as number and 
size of peaks (As seen in the Figures 17/18, and 24 and 27), one must still at least analyze 
fractions via RP-HPLC after purification because one CEX peak can sometimes 
correspond to two or more RP peaks.  Why this happens after purification and not before 
is unknown. 
 
Crystallization of Phosphono-CheY 
 Based on conditions used for the crystallization of CheY from T. maritima and for 
phosphono-CheY from E. coli, two screens were set up for phosphono-CheY 
crystallization.   The majority of the crystallization results were fairly similar to each 
other throughout all the conditions tested.  All wells in both trays produced at least some 
crystals, which in itself is successful as some crystallization trials take dozens of screens 
before some crystals are seen.  A few wells produced crystals which are candidate for X-
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ray diffraction.  The most common result was one which produced many small crystals 
(<0.2 mm) in a single drop.  Many of these crystals were either “X” or butterfly shaped, 
and were most prevalent in wells which contained high PEG concentrations (> 28%, 
which the majority of the wells contained).  Because PEG is the main precipitant during 
crystallization, the higher the PEG concentration, the more prevalent nucleation will be.  
Large number of nucleations will create a large number of crystals, while fewer 
nucleations will create less crystal formation, but usually larger more desirable crystals 
(as seen in wells with lower PEG concentrations).  This suggests that the initial PEG 
concentrations were a little too high and should be reduced in subsequent trials using 
these particular PEG molecular weights.  One use for these smaller crystals is to seed 
them to attempt to grow other larger crystals.  Seeding is a technique in which crystals 
from one drop are transferred into another drop and streaked across this new drop (28). 
 Another less common result was the formation of needles; these did not become 
prevalent until around 3 months into crystallization trials in the low pH acetate wells.  
Needles usually suggest that one is not far off from optimal crystallization conditions and 
only minor changes in pH and PEG concentration should be made (28).  After 5 months, 
many of the low pH wells which contained needles became clear, with no crystals at all 
present.   
 The wells which produced the most promising results throughout (those which 
contained single crystals >0.2 mm or crystals which were between 0.1-0.2 mm) were the 
same in both PEG molecular weights.  HEPES pH = 7.0 at PEG concentrations of 32% 
and less produced the best crystals; with the largest crystals seen at 26% PEG.  The other 
promising areas were in the low pH acetate wells.  At both PEG concentrations, the 
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acetate wells which contained 30% and 28% PEG concentrations produced very nice 
looking crystals.  Subsequent screens should be focused around these areas. 
Because crystals continued to change after 5 months, crystal trays should 
constantly be analyzed and never given up on.  Some suggest that crystal formation so 
late into the trials is a sign of protein degradation, however, successful X-ray analysis has 
been performed on crystals which are a year old or more.  
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Appendix 
Appendix A: Buffers For the Growth of CheY from Thermotoga maritima  
Terriffic Broth (1 L) 
Tryptone   12 g 
Yeast Extract   24 g 
KH2PO4     2 g 
K2HPO4*   12 g 
Glycerol   4 mL 
 
PMSF____________Concentration____________   g/mol_________      __10 mL 
PMSF             100 mM   174.2   .174g 
Ethanol          10 mL 
 
Lysis Buffer_______Concentration______ _______g/mol________________1 L 
HEPES           25 mM    238.3   5.96 g 
NaCl            500 mM   58.44   29.22 g 
Imidazole           5 mM    68.08   0.3404 g 
Azide            0.02%       0.05 g 
pH = 7.5 
 
Wash Buffer______ Concentration   g/mol   250 mL 
HEPES           20 mM    238.3   1.19 g 
NaCl            500 mM   58.44   7.31 g 
Imidazole           20 mM    68.08   .340 g 
Azide              0.02%       0.05 g 
pH = 7.5 
 
Elute Buffer ______ Concentration   g/mol   100 mL 
HEPES           20 mM    238.3   .596 g 
NaCl            500 mM   58.44   2.92 g 
Imidazole           200 mM   68.08   1.36 g 
pH = 7.5 
 
*K2HPO4•3H2O maybe be used in place since it is easier to weigh out, however, the 
weight of water must be taken into account for and corrected. 
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Appendix B:  Regeneration of Nickel Column 
Wash the column successively with the following: 
1. 2 vol regeneration buffer (6 M Gu-HCl, 0.2 M acetic acid) 
2. 5 vol water 
3. 3 vol 2% SDS 
4. 1 vol 25% ethanol 
5.  1 vol 50% ethanol 
6. 1 vol 75% ethanol 
7. 5 vol 100% ethanol 
8. 1 vol 75% ethanol 
9. 1 vol 50% ethanol 
10. 1 vol 25% ethanol 
11. 1 vol water 
12. 5 vol 100 mM EDTA, pH = 8.0 
13. 10 vol water 
14. Recharge column with 2 vol freshly made 100 mM NiSO4 
15. Wash with 2 vol water 
16. Wash with 2 vol regeneration buffer 
17. Equilibrate in 2 vol of a suitable buffer. 
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Appendix C: Other Possible Conditions for Phosphonomethylation of CheY 
 Several methods of alkylation not mentioned in the main text were tested, these 
methods have not been exhausted and have only minimal data, however; it is highly 
recommended that further work on the following conditions is put forth.   
Because metal ion is important during the alkylation reaction, the possibility of a 
larger metal ion may be advantageous.  Trivalent metals such as Nd3+, Tb3+, and Lu3+ 
were tested against CheY.  These metals were used only in a 5-10 mM concentration 
since their solubilities at higher pH values is low.  The results from these alkylations were 
similar to results obtained from Ba2+ and Sr2+; the RP-HPLC chromatograms would 
sometimes look clean with fairly high P-CheY yield, while others would exhibit high 
heterogeneity.  At the time of these alkylations, the buffer being used was 250 mM 
AMPSO at pH = 9.25, so it is possible that at lower pH values better results would have 
been obtained.  Because some clean alkylation reactions were observed, this are should 
be looked into further. 
Earlier, it was mentioned that the high organic content of the reaction was a 
possible cause of protein precipitation.  Because of this, Et3N was replaced with KOH 
and triethanolamine.  The data from these results suggest that alkylation is possible with 
other bases.  Alkylations with KOH showed a large amount of protein loss while 
alkylations with triethanolamine should similar results as Et3N.  One problem with the 
triethanolamine was its viscosity; it became very difficult to deliver the triethanolamine 
efficiently and methods for easier transfer should be looked into and retested.  
Two other experiments, which are somewhat related involve the use of different 
alkylating agents and while as higher temperature.  Because our protein is a thermophile 
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it is able to retain stability at high temperatures where other proteins would not be stable.  
In fact, a method of purifying CheY is to heat lysate up to 85oC and let all other 
molecules fall out of solution while CheY stays intact and in solution.  Higher 
temperature allows for modification with molecules that are less reactive than PMT such 
as phosphonomethylpentaflourobenzenesulfonate (PMFB), and 
phosphonomethyltresylate; at higher temperature, these molecules will become slightly 
more reactive.  Alkylations with these two molecules was carried out at 55oC at pH = 
9.25.  The results of these experiments were the same, all the protein had come out of 
solution.  The temperature is not the cause of this result as the protein sat in the warm 
water bath for several hours prior to alkylation with no precipitation.  Further work needs 
to be done using different temperatures and pH values. 
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Appendix D: Ion Exchange HPLC of Proteins 
 
I. Basics of Ion exchange HPLC  
The following is written with the assumption that a 4.6 x 200 mm, 5 um, 1000 Ǻ 
column will be used, PolyCAT A for cation exchange and PolyWAX LP for anion 
exchange. Proteins can be eluted using either an increasing gradient of salt or pH 
(decreasing pH in anion exchange).  
The purpose of IEC is to separate compounds based on their difference in charge 
state. This is advantageous when you have a mixture of molecules containing groups such 
as NH3+, COO-, PO4-, or SO3-2; each can be separated from each other using this 
technique. IEC has several advantages over RP-HPLC: 
- Higher resolving power 
- Higher recoveries 
- Preformed under non-denaturing conditions (especially advantageous) 
When deciding on whether to use cation or anion exchange for a protein a good rule of 
thumb is as follows: 
Typically, a protein will bind to a cation exchange resin if the buffer pH is lower than the 
isoelectric point (pI) of the protein, and will bind to an anion exchange resin if the pH is 
higher than the pI. 
In other words, if pH of the buffer is below the pI, the protein will have a net positive 
charge, therefore wanting to exchange with cations. If pH of the buffer is above pI, the 
protein will have a net negative charge, warranting exchange with anions. This does not 
necessarily mean that either cation or anion exchange can be used for one protein if one 
place it in a specific buffer. There are several restrictions: 
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- Both the cation and anion exchange columns have a pH range, if one goes outside 
of these ranges the column matrix can be ruined. One would not want to run a 
cation exchange column at pH 8 for example. 
- The protein must be stable at the pH used. A protein may precipitate out of 
solution if pH is too high or too low, or more importantly (and more likely to 
happen) if it is at or too near the pI of the protein. Cation exchange using a buffer 
at 6.20 would not be a good choice for a protein with a pI of 6.1 for example. 
- A weak cation or anion exchange column can also become uncharged at the 
wrong pH. 
II. Preparing Samples 
Samples should always be exchanged into a buffer that is the same as the starting 
conditions of the gradient. Usually this means that one’s protein will be loaded at low 
ionic strength and/or pH. If one fails to do this, the protein will likely not stick to the 
column and the column will become unequilibrated.  
 Both analytical and preparative work can be performed on this column, and 
samples should be prepared as follows: 
For qualitative work: 
A sample that is   ~0.5 ug/uL is sufficient (typically 45 ug in 120 uL). 50 uL of sample is 
loaded into a 20 uL sample loop. Excess is used to ensure any previous sample is washed 
out of the sample loop.  
For preparative work: 
As much as 3 mg can be loaded onto a 9.4 mm ID column without losing sufficient 
resolution (This depends on protein MW however, this is using a protein with MW of 
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13.5 kDa). Here a 2 mL sample loop is used and multiple injections can be used if 
needed.  If multiple injections are needed, one must unplug the injector from the HPLC 
so the method does not start when the injector is turned to “load.”  Also, ensure there is 
sufficient time between multiple injections to be sure sample is out of the sample loop. 
III. Preparing Mobile Phases 
The buffer used should have a pH that is at least 2 pH units away from the pI of the 
protein, this ensures the protein is in its correctly charged form and it is safely away from 
the pI (avoiding precipitation). In order to pick a useful buffer two things must be taken 
into consideration: 
- The pka of that buffer must be within the range of pH you are using 
- The buffer ions should be the same charge as the ion-exchanger to avoid 
competition with the sample. For example, an anionic buffer should be used with 
a cation-exchange column. 
Some commonly used buffers for cation exchange are HEPES, Phosphate, Acetic Acid, 
and Formic Acid. Common anion exchange buffers are bis-Tris, Piperazine, and Tris-Cl. 
The counter-ion used in ion exchange is also an important factor in elution of a protein. 
Counter-ions are the ions which will ultimately exchange with the resin to elute bound 
protein. For example, Na+ ions (from NaCl) eluting a bound positively charged protein. 
The stronger the counter-ion, the quicker a protein will elute from the column, and vice 
versa for a weaker counter-ion.  Below are some common counter ions in cation and 
anion exchange and their strengths of displacement: 
Cation exchange: Mg2+ > Ca2+ > NH4+ > Na+ > K+ 
Anion exchange: SO4-2 > HPO4-2 > Cl- > CH3COO- 
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Once a buffer and pH is chosen, two mobile phases will be made up (denoted MPA and 
MPB), one of low ionic strength (with low or no salt) and one of higher ionic strength 
(with higher salt concentrations). For example, a typical cation exchange buffer could be 
as follows: 
MPA: 10 mM KH2PO4, pH = 6.20 
MPB: 10 mM KH2PO4, 500 mM NaCl, pH = 6.20 
All reagents must be HPLC grade and made up in Mill-Q water. Filtering of the mobile 
phases under vacuum are done with Pall GH polypro (0.45 um) filters. It is important that 
all glassware is acid washed with HNO3/H2SO4 to ensure all detergents are absent. 
IV. Method Development 
Before a run is preformed on a sample the column must be equilibrated twice, once to 
convert to the column to the correct salt form, and once to wash away excess salt. With a 
flow rate of 1 mL/min, 100% of MPB (high salt) will be run through the column for 30 
minutes to convert the column to the appropriate form (if using NaCl, converting to Na+ 
form for cation exchange or Cl- form for anion exchange). Following this, 100% MPA is 
flowed through for 30 minutes to wash away excess salt, if this is not done sample will 
not bind to the column.  
 For a new protein, a broad gradient will be run first to find an approximate % of 
MPB a sample will elute. For example, a first run would be something like 0  100% 
MPB over 60 minutes. If the protein elutes at 30 minutes one can calculate the 
approximate salt concentration and shallow the gradient for better separation. In the case 
using the mobile phases listed above, the protein would elute at ~250 mM NaCl. 
Knowing this, the gradient can be adjusted accordingly to where one wants the protein to 
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elute in the gradient.  Following the run, the column must be requilibrated as stated above 
if it is to be used again within a day or so. For storage over several days it is preferred to 
store the column in water to avoid clogging and corrosion from salts. For long term 
storage over several weeks or more it is preferred to store the column in 50% ACN/H2O 
in the refrigerator. 
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Appendix E: Native PAGE 
 Besides RP-HPLC and CEX HPLC, another method to verify the quality of 
alkylation was sought out.  One method which seemed attractive was the use of Native 
PAGE, a gel electrophoresis method similar to SDS-PAGE which separates proteins 
based on molecular weight in non-denaturing conditions.   
High pH, neutral pH, and low pH buffer systems were tested for native gel 
analysis. The low pH system contained an acetic acid-KOH buffer for both stacking (pH 
= 6.7) and resolving (pH = 4.3) buffers with a β-alanine-acetic acid electrophoresis buffer 
(pH = 4.5).  The neutral pH system contained a Tris-HCl buffer for a resolving buffer (pH 
= 7.9) and an Imidazole-HCl buffer for the stacking buffer (pH = 6.2) with a Tris-glycine 
electrophoresis buffer (pH = 7.3).  The high pH system contained a Tris-glycine buffer 
for both stacking (pH = 6.8) and resolving (pH = 8.8) buffers with a Tris-glycine 
electrophoresis buffer (pH = 8.3).  Right before the gel is poured the stacking buffers had  
4.5% acrylamide, 0.0005% v/v riboflavin, and 0.00075% v/v TEMED (0.0075% v/v for 
low pH buffer) added to it.  The resolving buffers had 13.5% acrylamide, 0.075% APS, 
and 0.00075% TEMED (0.0075% for low pH buffer) added to it prior to the pouring of 
the gel.  Both buffers are degassed (without APS and TEMED present) before pouring 
the gel.   
The Resolving gel is poured first to ~3.5 cm from the top of the glass plate, and a 
few drops of isobutanol are applied to the top of the resolving gel to level the top and rid 
of any bubbles. The gel is left to sit until polymerization occurs, which is usually around 
15 minutes. After polymerization, the isobutanol is poured off and the stacking gel is 
poured on top of the resolving gel to the top of the glass plate; a comb is put in place for 
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well formation.  Polymerization will occur once the gel is illuminated with UV light from 
a UV lamp (or any other strong UV source), normal fluorescent light is not sufficient 
enough for polymerization by riboflavin. The gel is done polymerizing once the stacking 
gel is no longer glowing bright yellow under the UV light. 
Samples should contain 10-50 µg of protein for a single protein, and 50-100 µg 
for a mixture. All samples should contain 10% v/v glycerol (or sucrose), a 10 fold 
dilution of the stacking gel buffer used, and 0.0025% v/v tracking dye (methylene green 
for low and neutral pH, and bromophenol blue for high pH). For the low and neutral pH 
systems the gels run positive to negative and the gel housing must be put in backwards 
(red connecting to black and black connecting to red), while the high pH system runs 
normally, negative to positive.  
Results of the gel runs were inconclusive as they were hard to interpret.  Because 
the pI of CheY is relatively high, the low pH system was preferred, though all the 
systems were tested.  The low pH system showed only one band when a reaction mixture 
was run on the gel.  Two explanations can be made for this results, one is that the 
molecular weight difference between phosphono-CheY and CheY is not great enough to 
resolve (M.W. difference = 94 amu), and the other is the amount of phosphono-CheY 
might not be great enough to detect using conventional Commaisse stain.  The literature 
suggests otherwise on both accounts, but because these gels were not precast from a 
manufacturer, technicalities arising from making them in lab may have affected 
resolution and detection.  Silver staining is a method which can be used to detect smaller 
amount of protein, and that method may be worth investigating if this technique is 
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employed in the future.  The neutral pH system gave almost the exact same results as the 
low pH system. 
The high pH system did not work at all as should have been expected.  Because 
the stacking gel pH is lower than the pI value of CheY and the resolving gel is higher, 
there are opposing forces at work.  In the stacking gel, CheY would be negatively 
charged, and in the resolving gel, CheY would be positively charged.  This method 
therefore resulted in no movement of the CheY band. 
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Appendix F: Oxidation of Amino Acid Derivatives 
 Amino acid derivatives, focused mostly around modifications to derivatives of 
cysteine, were synthesized with the idea that they were to be inhibitory analogs to the 
enzyme aspartate semialdehyde dehydrogenase (ASADH).  The majority of the reactions 
were oxidation reactions on the sulfur of cysteine to create various sulfoxides and 
sulfones.  The oxidations were carried out on four main cysteine derivatives; they are s-
methylcysteine, S-allycysteine, phosphonomethylcysteine (PMC), and 
triflouroethylcysteine (Figure A1).  All the compounds are available commercially with 
the exception of phosphonomethylcysteine, which is synthesized using cysteine and PMT 
in the presence of 3.0 equivalents of 6 N NaOH, and triflourethylcysteine, which was 
synthesized and given to us as a gift by Dr. DesMartaeu’s lab at Clemson University.  
Several oxidation methods were tried and others are known but have not yet been 
attempted.  Three of the oxidation agents tested were hydrogen peroxide, sodium 
periodate, and sodium perborate; TPAP/NMO and MCPBA are oxidation agents which 
still need to be tested.   
 Sulfoxide formation was achieved with all of the given molecules above as 
suggested by 1H, 13C, and 31P NMR.  The method by which each was formed however 
varied from molecule to molecule; sulfone formation was only achieved with one 
(possibly another as well) of the molecules.   
 As mentioned above, phosphonomethylcysteine was synthesized by reacting 
cysteine with PMT in the presence of 3.0 equiv. of 6N NaOH; this however did not 
produce 100% conversion and the product must be cleaned via Dowex-1 and -50 to rid of 
free cysteine and the hydrolysis product of PMT.  Sulfoxide formation is achieved by 
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reacting PMC with 1.1 equivalents of H2O2 (or 10% v/v of a 30% solution) until the 
reaction is virtually complete by 31P NMR.  Sulfone formation has been achieved with 
this compound as well by oxidizing with 3.0 equivalents of H2O2.  PMC reactions were 
done extensively by Neal Johnson and Billy Kish (unpublished results). 
 S-allylcysteine (1H NMR spectra, Figure A2) was oxidized to sulfoxide using 
approximately the same method used for PMC, sulfoxide formation started to occur after 
the introduction of 1.1 equivalents of 10.6 M H2O2.  The overnight reaction went very 
far, but not quite all the way to sulfoxide (Figure A3a.); small peaks corresponding to 
starting material at 2.85 ppm are still present at ~5%.  Sulfoxide formation shows a 
downfield shift off all sulfide protons between the 2.5 and 4.5 ppm range; the expected 
shift of ~0.5 ppm downfield is seen here.  We note that the change in peak shape as 
sulfoxide formation introduces another chiral center in the molecule.  Because one chiral 
is already present, the formation of another will add further complexity to the spectra as 
the protons on either side of the sulfur are magnetically unequivalent; in other words, the 
two protons on the carbon next to sulfur do not have the same chemical shift.  The 
protons therefore are diastereotopic and 2 ABX patterns are seen.  Because the reaction 
was still somewhat incomplete, the reaction was put at 37oC and left to sit overnight.  The 
next day 1H NMR spectra suggested complete sulfoxide reactivity (Figure A3b.); we note 
that the small peaks at 2.85 ppm are gone as compared to the previous spectra. 
  With this s-allylcysteine, a new methodology was employed to test for 
sulfoxide/sulfone formation as well (H2O2 had failed for sulfone attempt), that was the 
use of sodium periodate.  3.0 equivalents of periodate at .5 M (in H2O) was added to 167 
mM s-allylcysteine and let to sit for 30 hours.  In the first 20 minutes crystals had formed, 
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however they eventually disappeared and the reaction became clear with a slightly yellow 
color.  After 30 hours, a Dowex-50 (AG 50W-X8 resin from Bio-Rad) cation exchange 
column was used to rid of any Na+ ions and to purify and sulfoxide/sulfone away from 
any starting material.  The amount of Dowex needed is calculated by the following 
equation: 
mmol of product plus sodium ion *(1/1.7)(20) = mL of gel warranted 
In this equation, the 1/1.7 factor states that 1 mL of gel will bind 1.7 mmol equivalents of 
ion and the 20 is for a 20 fold increase of column size which is suggested over amount of 
ion present.  If a new column is poured it is suggested to rinse the beads with several 
washes of ethanol first, to rid the resin of an orange impurity, and follow by rinsing with 
several DI water washes.  
 Once the column is poured, it is first washed with 2 column volumes of 1 M HCl 
(to convert to H+ form) and subsequently washed with water until neutral pH is reached.  
The sample is applied once it is diluted to ½ of the column volume, the drip rate should 
be ~2 mL/min, and two separate washes are applied.  The first wash is 2 column volumes 
of water, and the second wash is 3 column volumes of 2 N NH4OH.  In this case the 
water wash was an orangey spongy looking substance, while the ammonia wash was a 
crystalline/yellowish substance; in this case it was expected that the product would elute 
in the ammonia wash.  Upon 1H and 13C analysis of the ammonia wash, a mixture of 
sulfoxide and sulfone was suspected.  Peaks which agreed with sulfoxide formation as 
compared with earlier peroxide oxidations was seen, however, there were new peaks 
which were believed to be consistent with sulfone formation.  At this point, an additional 
2 equivalents of periodate were added to the NMR tube, while the main reaction flask 
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was left alone.  The following day the 1H NMR spectra (Figure A4) suggested mostly 
sulfone.  The major change to note in this spectra its lessened complexity.  Addition of a 
second oxygen atom to the sulfur atom causes sulfur to lose its chirality.  Because of this, 
the protons next to sulfur are now only diastereotopic to one chiral center and not two. 
TLC was also run on s-allyl-cysteine; it was done on both the reaction flask (no 
additional periodate) and the NMR tube (additional periodate) using a 70/30 EtOH/H2O 
solvent system.  Upon analysis, the reaction flask showed a single spot corresponding to 
sulfoxide formation, while the NMR tube showed two spots, one corresponding to 
sulfoxide and one with a lower Rf value which is presumed to be sulfone. 
 S-methylcysteine was oxidized using a variety of different compounds.  The first 
two oxidation systems tested were composed of 1.1 equivalents of 30% H2O2 and another 
of 500 mM sodium periodate.  Both of these reactions were done as NMR size reactions 
(performed in NMR tube) in D2O as the solvent.  The reactions were purified via Dowex-
50 as discussed above.  Conformation of sulfoxide formation is based on both 1H and 13C 
NMR.  Two other systems were also tested against s-methylcysteine, both used 1.1 
equivalents of sodium perborate as the oxidant with one in d-acetic acid and the other in 
d-methanol.  MCPBA was another possibility; however, it was never attempted.  Both 
perborate systems worked somewhat with about a 50/50 mixture of sulfoxide and starting 
material after an overnight reaction was performed.  s-methylcysteine was used more as a 
test compound since its sulfoxide form is available commercially. 
 The final compound was one which was synthesized and provided to us by Dr. 
DesMarteau’s lab at Clemson University.  Triflouroethylcysteine (1H NMR spectra in 
Figure A5) was first tested against 1.1 equivalents of H2O2; the reaction had not 
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proceeded at all after 2 days and it was put on reflux.  After 1 week in peroxide and 4 
days on reflux the reaction still had not proceeded at all and another method was 
attempted.  1.1 equivalents of sodium periodate in D2O was tested against the triflouro 
compound and after a day had seemed to proceed somewhat.  Although the 1H NMR 
spectra was messy (Figure A6), likely due to diastereomers, the chemical shift difference 
was consistent with sulfoxide formation.  In this case it was believed that little sulfide 
starting material was left and the majority of the product was sulfoxide.  In an attempt to 
clean up the spectra and the compound, a Dowex-50 column (as above) was run on the 
reaction.  Upon analysis of both the water wash and ammonia wash, no product at all was 
found.  It is unknown what could have happened to our compound besides some type of 
chemical degradation. 
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Figure A1. Structures of the following molecules: a.) phosphonomethylcysteine b.) s-allylcysteine c.) s-
methylcystein d.) triflouroethylcysteine e.) general sulfoxide and sulfone oxidation states. 
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Figure A2. 1H NMR spectra of s-allylcysteine. 
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B. 
Figure A3.  a.) 1H NMR spectra of s-allylcysteine in peroxide overnight; forming mostly sulfoxide. b.) 1H 
NMR spectra of s-allylcysteine in peroxide for 39 hours and heated up; forming all sulfoxide. 
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Figure A4.  1H NMR spectra of s-allylcysteine with 3.0 equivalents of NaOI4 after 30 hours.  Product is 
believed to be a mixture of sulfoxide and sulfone. 
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Figure A5.  1H NMR spectra of Triflouroethylcysteine. 
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Figure A6.  1H NMR spectra of Triflouroethylcysteine after an overnight in NaOI4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
116 
Appendix G: MALDI-TOF Mass spectrometry of Phosphono-CheY 
 MALDI-TOF MS was tested on protein purified by early purification techniques 
involving the 10 mM phosphate method.  Phosphono-CheY from the purification seen in 
Figure 23a was sent to Cornell University for analysis.  The protein sent was not pure 
phosphono-CheY, but only ~ 70%.  Figure A7 shows the mass spectrum of this sample.  
Two masses are represented in this spectrum, one of 13470.7676, and one of 13582.0215.  
The lower molecular weight corresponds to native D54C/C81S CheY with the added 
GSH sequence at the N-terminus.  The higher molecular weight (111 amu greater) 
corresponds to the addition of the phosphonomethyl group (+15) and an oxygen (+16).  
The extra oxygen is suspected to be due to oxidation of methionine. 
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Figure A7.  MALDI-TOF mass spectrum of the purified phosphono-CheY seen in Figure 23. 
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